{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":503,"total_is_capped":false,"direct_labels_cover":1,"predictions_cover":503,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"c6c8d2e0904f","filters":{"venue":"Clinical Lymphoma Myeloma & Leukemia"}},"results":[{"id":"W2020431842","doi":"10.1016/j.clml.2012.08.003","title":"An Open-Label Single-Arm Pilot Phase II Study (PX-171-003-A0) of Low-Dose, Single-Agent Carfilzomib in Patients With Relapsed and Refractory Multiple Myeloma","year":2012,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary; Beatrice Hunter Cancer Research Institute; Saint John Regional Hospital; Princess Margaret Cancer Centre; University of Toronto","funders":"Onyx Pharmaceuticals","keywords":"Carfilzomib; Medicine; Multiple myeloma; Bortezomib; Lenalidomide; Internal medicine; Thalidomide; Refractory (planetary science); Adverse effect; Regimen; Clinical endpoint; Phases of clinical research; Proteasome inhibitor; Anemia; Oncology; Surgery; Clinical trial; Gastroenterology","authors":[{"name":"Sundar Jagannath","is_ca":false},{"name":"Ravi Vij","is_ca":false},{"name":"A. Keith Stewart","is_ca":false},{"name":"Suzanne Trudel","is_ca":true},{"name":"Andrzej Jakubowiak","is_ca":false},{"name":"Tony Reiman","is_ca":true},{"name":"George Somlo","is_ca":false},{"name":"Nizar J. Bahlis","is_ca":true},{"name":"Sagar Lonial","is_ca":false},{"name":"Lori Kunkel","is_ca":false},{"name":"Alvin Wong","is_ca":false},{"name":"Robert Z. Orlowski","is_ca":false},{"name":"David S. Siegel","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.09475273562003522,"gpt":0.3770711989469108,"spread":0.2823184633268755,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002120474,0.002373157,0.003529286,0.0006366941,0.0007014397,0.001226875,0.001463571,0.001699417,0.004866842],"category_scores_gemma":[0.001173212,0.0009171299,0.001816292,0.0005654592,0.00218639,0.001786346,0.0005022316,0.005934832,0.001435077],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00126551,"about_ca_system_score_gemma":0.00251863,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001919029,"about_ca_topic_score_gemma":0.003966215,"domain_scores_codex":[0.9993562,0.0002906114,0.00002236735,0.0001021096,0.00004701399,0.0001816068],"domain_scores_gemma":[0.9987871,0.0002089023,0.0001415266,0.0001163012,0.00005964131,0.0006864474],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8303282,0.0825691,0.003027366,0.000468515,0.0007914387,0.0001907053,0.0002415891,0.001771387,0.02812409,0.0002803481,0.003222897,0.04898437],"study_design_scores_gemma":[0.6492838,0.3413764,0.005704093,0.00001094639,0.0002089718,0.0001240126,0.00004579994,0.0007522592,0.001285955,0.0001587203,0.001022007,0.00002715568],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9912827,0.001169954,0.0008010677,0.0006970514,0.0002104879,0.002740238,0.001191532,0.000189533,0.001717533],"genre_scores_gemma":[0.9868845,0.001151889,0.002139965,0.0009932818,0.0003801452,0.003319927,0.002347295,0.00005758246,0.002725462],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004866842,"threshold_uncertainty_score":0.01628119,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2808748371","doi":"10.1016/j.clml.2018.06.018","title":"Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study","year":2018,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network","funders":"Janssen Pharmaceuticals; Takeda Oncology","keywords":"Medicine; Multinational corporation; Multiple myeloma; Clinical Practice; Oncology; Internal medicine; Family medicine; Law","authors":[{"name":"Mohamad Mohty","is_ca":false},{"name":"Evangelos Terpos","is_ca":false},{"name":"María‐Victoria Mateos","is_ca":false},{"name":"Michèle Cavo","is_ca":false},{"name":"Sandra Lejniece","is_ca":false},{"name":"Meral Beksaç","is_ca":false},{"name":"Mohamed Amine Bekadja","is_ca":false},{"name":"Wojciech Legieć","is_ca":false},{"name":"Meletios Α. Dimopoulos","is_ca":false},{"name":"Svetlana Stankovic","is_ca":false},{"name":"María Soledad Durán","is_ca":false},{"name":"Valerio De Stefano","is_ca":false},{"name":"Alessandro Corso","is_ca":false},{"name":"Yulia Kochkareva","is_ca":false},{"name":"Edward Laane","is_ca":false},{"name":"Christian Berthou","is_ca":false},{"name":"Hans Salwender","is_ca":false},{"name":"Zvenyslava Masliak","is_ca":false},{"name":"Valdas Pečeliūnas","is_ca":false},{"name":"Wolfgang Willenbacher","is_ca":false},{"name":"João Pedro Silva","is_ca":true},{"name":"Vernon Louw","is_ca":false},{"name":"Damir Nemet","is_ca":false},{"name":"Zita Borbényi","is_ca":false},{"name":"Uri Abadi","is_ca":false},{"name":"Robert Schou Pedersen","is_ca":false},{"name":"Peter Černelč","is_ca":false},{"name":"Anna Potamianou","is_ca":false},{"name":"Catherine Couturier","is_ca":false},{"name":"Caroline Feys","is_ca":false},{"name":"Florence Thoret-Bauchet","is_ca":false},{"name":"Mario Boccadoro","is_ca":false},{"name":"Rose‐Marie Hamladji","is_ca":false},{"name":"Hocine Ait Ali","is_ca":false},{"name":"Selma Hamdi","is_ca":false},{"name":"Hadj Touhami","is_ca":false},{"name":"Nourredine Sidi Mansour","is_ca":false},{"name":"Werner Linkesch","is_ca":false},{"name":"Robert S. Pedersen","is_ca":false},{"name":"Niels Abildgaard","is_ca":false},{"name":"Marju Hein","is_ca":false},{"name":"Jean Richard Eveillard","is_ca":false},{"name":"Abderrazak El Yamani","is_ca":false},{"name":"Philippe Moreau","is_ca":false},{"name":"Laurence Sanhès","is_ca":false},{"name":"G. Lepeu","is_ca":false},{"name":"Kamel Laribi","is_ca":false},{"name":"Éric Jourdan","is_ca":false},{"name":"Olivier Fitoussi","is_ca":false},{"name":"Olivier Allangba","is_ca":false},{"name":"Joël Fleury","is_ca":false},{"name":"Martine Escoffre","is_ca":false},{"name":"Riad Benramdane","is_ca":false},{"name":"Guillaume Cartron","is_ca":false},{"name":"Gérard Dine","is_ca":false},{"name":"Eric Legouffe","is_ca":false},{"name":"Hanns‐Detlev Harich","is_ca":false},{"name":"Thomas Illmer","is_ca":false},{"name":"Steffen Dörfel","is_ca":false},{"name":"Carla Hannig","is_ca":false},{"name":"Michael Koenigsmann","is_ca":false},{"name":"Gabriele Prange‐Krex","is_ca":false},{"name":"Ingo Tamm","is_ca":false},{"name":"W. Zeller","is_ca":false},{"name":"M. Maasberg","is_ca":false},{"name":"Rudolf Schlag","is_ca":false},{"name":"Martine Klausmann","is_ca":false},{"name":"Jens Uhlig","is_ca":false},{"name":"Burkhard Alkemper","is_ca":false},{"name":"Stefan Schütz","is_ca":false},{"name":"Hans-Werner Tessen","is_ca":false},{"name":"Benno Mohr","is_ca":false},{"name":"Peter Schmidt","is_ca":false},{"name":"Bernhard Heinrich","is_ca":false},{"name":"Holger Hebart","is_ca":false},{"name":"G. Seipelt","is_ca":false},{"name":"Thomas Zoeller","is_ca":false},{"name":"Frank Heits","is_ca":false},{"name":"Clemens Müller‐Naendrup","is_ca":false},{"name":"Richard Hansen","is_ca":false},{"name":"Roland Repp","is_ca":false},{"name":"Ludwig Fischer von Weikersthal","is_ca":false},{"name":"Rudolf Schmits","is_ca":false},{"name":"Jörg Heßling","is_ca":false},{"name":"B. Krammer-Steiner","is_ca":false},{"name":"Viktor Janzen","is_ca":false},{"name":"Michael Schauer","is_ca":false},{"name":"M Grüner","is_ca":false},{"name":"Jens Kisro","is_ca":false},{"name":"Claudio Denzlinger","is_ca":false},{"name":"Werner Freier","is_ca":false},{"name":"Christian Junghanß","is_ca":false},{"name":"Martin Görner","is_ca":false},{"name":"Katharina Laichinger","is_ca":false},{"name":"Helmut Ostermann","is_ca":false},{"name":"Heinz Dürk","is_ca":false},{"name":"Georg Heß","is_ca":false},{"name":"Gernot Reich","is_ca":false},{"name":"Panagiota Matsouka","is_ca":false},{"name":"Anastasia Pouli","is_ca":false},{"name":"Αchilles Anagnostopoulos","is_ca":false},{"name":"Tamás Masszi","is_ca":false},{"name":"J Ivánýi","is_ca":false},{"name":"Árpád Szomor","is_ca":false},{"name":"Arnon Nagler","is_ca":false},{"name":"Hila Magen","is_ca":false},{"name":"Irit Avivi","is_ca":false},{"name":"Miriam Quitt","is_ca":false},{"name":"Antonio Palumbo","is_ca":false},{"name":"Tommaso Zà","is_ca":false},{"name":"Daniele Vallisa","is_ca":false},{"name":"Roberto Foà","is_ca":false},{"name":"Alberto Bosi","is_ca":false},{"name":"Angelo Vacca","is_ca":false},{"name":"Francesco Lanza","is_ca":false},{"name":"Giulia Palazzo","is_ca":false},{"name":"Giuseppe Avvisati","is_ca":false},{"name":"Felicetto Ferrara","is_ca":false},{"name":"Ugo Consoli","is_ca":false},{"name":"Maria Cantonetti","is_ca":false},{"name":"Emanuele Angelucci","is_ca":false},{"name":"Catello Califano","is_ca":false},{"name":"Francesco Di Raimondo","is_ca":false},{"name":"Attilio Guarini","is_ca":false},{"name":"Maurizio Musso","is_ca":false},{"name":"Michele Pizzuti","is_ca":false},{"name":"Nicola Giuliani","is_ca":false},{"name":"Antonio Ardizzoia","is_ca":false},{"name":"Nicola Di Renzo","is_ca":false},{"name":"Gianluca Gaïdano","is_ca":false},{"name":"Alessandro Gozzetti","is_ca":false},{"name":"Vincenzo Pitini","is_ca":false},{"name":"Gabriella Farina","is_ca":false},{"name":"Riccardo Centurioni","is_ca":false},{"name":"Paolo de Fabritiis","is_ca":false},{"name":"Francesco Iuliano","is_ca":false},{"name":"Giorgio La Nasa","is_ca":false},{"name":"Giacinto La Verde","is_ca":false},{"name":"Fabrizio Pane","is_ca":false},{"name":"Umberto Recine","is_ca":false},{"name":"Maria La Targia","is_ca":false},{"name":"Giuseppe Mineo","is_ca":false},{"name":"Clotilde Cangialosi","is_ca":false},{"name":"Daniele Fagnani","is_ca":false},{"name":"Augusto B. Federici","is_ca":false},{"name":"Atelda Romano","is_ca":false},{"name":"Giorgina Specchia","is_ca":false},{"name":"Sergio Storti","is_ca":false},{"name":"Velia Bongarzoni","is_ca":false},{"name":"Andrea Bacigalupo","is_ca":false},{"name":"Marco De Gobbi","is_ca":false},{"name":"Giancarlo Latte","is_ca":false},{"name":"Donato Mannina","is_ca":false},{"name":"Silvana Capalbo","is_ca":false},{"name":"Mindaugas Jurgutis","is_ca":false},{"name":"Dariusz Woszczyk","is_ca":false},{"name":"Jadwiga Hołojda","is_ca":false},{"name":"Slawomir Gornik","is_ca":false},{"name":"Andrzej Pluta","is_ca":false},{"name":"Elżbieta Morawiec-Szymonik","is_ca":false},{"name":"Sławomira Kyrcz‐Krzemień","is_ca":false},{"name":"Wojciech Homenda","is_ca":false},{"name":"Sebastian Grosicki","is_ca":false},{"name":"K Sułek","is_ca":false},{"name":"Andrzej Lange","is_ca":false},{"name":"Janusz Kłoczko","is_ca":false},{"name":"Jolanta Starzak-Gwóźdź","is_ca":false},{"name":"Andrzej Hellmann","is_ca":false},{"name":"Mieczysław Komarnicki","is_ca":false},{"name":"Kazimierz Kuliczkowski","is_ca":false},{"name":"Carolina Viveiros","is_ca":false},{"name":"Cristina Gonçalves","is_ca":false},{"name":"Natalia Esefyeva","is_ca":false},{"name":"Julia Kochkareva","is_ca":false},{"name":"Kamil Kaplanov","is_ca":false},{"name":"Elena Volodicheva","is_ca":false},{"name":"Elena Laricheva","is_ca":false},{"name":"Valentina Dergacheva","is_ca":false},{"name":"Marina Chukavina","is_ca":false},{"name":"Natalia Volchenko","is_ca":false},{"name":"И. Н. Назарова","is_ca":false},{"name":"Л. В. Анчукова","is_ca":false},{"name":"Е. В. Ованесова","is_ca":false},{"name":"Т. А. Гриценко","is_ca":false},{"name":"Galina Salogub","is_ca":false},{"name":"Ludmila Magomedova","is_ca":false},{"name":"Irina Kuznetsova","is_ca":false},{"name":"Svetlana Osyunikhina","is_ca":false},{"name":"Olga V. Serdyuk","is_ca":false},{"name":"Elena Karyagina","is_ca":false},{"name":"Valentina Ivanova","is_ca":false},{"name":"S Cernelc","is_ca":false},{"name":"Corlia Coetzee","is_ca":false},{"name":"Karen Gunther","is_ca":false},{"name":"Dhayanithi Moodley","is_ca":false},{"name":"Soledad Durán","is_ca":false},{"name":"Asunción Echeveste Gutiérrez","is_ca":false},{"name":"Jaime Pérez de Oteyza","is_ca":false},{"name":"Francisco Capote","is_ca":false},{"name":"María Casanova","is_ca":false},{"name":"Eduardo Ríos","is_ca":false},{"name":"Jeronima Ibañez-Garcia","is_ca":false},{"name":"María José Herranz","is_ca":false},{"name":"Belén Hernández","is_ca":false},{"name":"Sara Sanchez Sanchez","is_ca":false},{"name":"Fernando Escalante","is_ca":false},{"name":"Fernando Carnicero","is_ca":false},{"name":"Mercedes Gironella","is_ca":false},{"name":"Rafael Martínez","is_ca":false},{"name":"A. López de la Guía","is_ca":false},{"name":"Luis Palomera","is_ca":false},{"name":"Rebeca Iglesias","is_ca":false},{"name":"F. Solano Ramos","is_ca":false},{"name":"Javier de la Serna","is_ca":false},{"name":"Pedro Garcia Sanchez","is_ca":false},{"name":"Juan Besalduch Vidal","is_ca":false},{"name":"Miguel Diaz Morfa","is_ca":false},{"name":"Turkey – Meral Beksac","is_ca":false},{"name":"Filiz Vural","is_ca":false},{"name":"Yıldız Aydın","is_ca":false},{"name":"Ali Ünal","is_ca":false},{"name":"Hakan Göker","is_ca":false},{"name":"Oktay Bilgir","is_ca":false},{"name":"Birol Güvenç","is_ca":false},{"name":"Mehmet Turgut","is_ca":false},{"name":"Gülsüm Özet","is_ca":false},{"name":"Rıdvan Ali","is_ca":false},{"name":"Maryna Kyselyova","is_ca":false},{"name":"Nataliia Glushko","is_ca":false},{"name":"Renata Vybyrana","is_ca":false},{"name":"Ігор Миколайович Скрипник","is_ca":false},{"name":"N. M. Tretyak","is_ca":false},{"name":"Tetiana Kharchevska","is_ca":false},{"name":"Iryna Dyagil","is_ca":false},{"name":"Tetiana Popovska","is_ca":false},{"name":"V N Shimanskiy","is_ca":false},{"name":"Tamila Lysa","is_ca":false},{"name":"Hanna Oliynyk","is_ca":false},{"name":"Kateryna Vilchevskaya","is_ca":false},{"name":"Iryna Kryachok","is_ca":false},{"name":"Yuriy Popovych","is_ca":false},{"name":"Natalia Romanyuk","is_ca":false},{"name":"Polina Kaplan","is_ca":false},{"name":"Grygoriy Rekhtman","is_ca":false},{"name":"Halyna Pylypenko","is_ca":false},{"name":"В. В. Козлов","is_ca":false},{"name":"Johannes Drach","is_ca":false},{"name":"Jean‐Luc Harousseau","is_ca":false},{"name":"Hermann Einsele","is_ca":false},{"name":"Hartmut Goldschmidt","is_ca":false},{"name":"Thierry Façon","is_ca":false},{"name":"Mauricette Michalet","is_ca":false},{"name":"Savchenko Vg","is_ca":false},{"name":"Javier de la Rubia","is_ca":false},{"name":"Gordon Cook","is_ca":false},{"name":"Ulf‐Henrik Mellqvist","is_ca":false},{"name":"H Ludwig","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08839271982467811,"gpt":0.45732599415284,"spread":0.3689332743281619,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009338806,0.0004724647,0.0004881248,0.0009956895,0.0008000002,0.001838255,0.0008455741,0.0009636946,0.001515817],"category_scores_gemma":[0.01682559,0.0005487888,0.0008649181,0.00222586,0.0009673513,0.001772809,0.001549466,0.0008631347,0.0003623905],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008994888,"about_ca_system_score_gemma":0.001459643,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005855038,"about_ca_topic_score_gemma":0.007786778,"domain_scores_codex":[0.9925548,0.004936364,0.0006382077,0.0007202477,0.0007004882,0.0004498521],"domain_scores_gemma":[0.9785306,0.004415755,0.01230967,0.001309961,0.001502121,0.001931902],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003384223,0.0003173927,0.9978477,0.00002264317,0.0001334046,0.00002698823,0.0002969319,0.00002363031,0.00002531594,0.00001381139,0.0001047338,0.0008492355],"study_design_scores_gemma":[0.0001214747,0.0006160576,0.9978132,0.0000189166,0.00007207878,0.00008924222,0.0008247041,0.0001708581,0.00001323828,0.00001571857,0.0002353287,0.00000926646],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9988676,0.0001929649,0.00007949923,0.0001083317,0.000008451772,0.00006620742,0.0003507465,0.000003476791,0.000322658],"genre_scores_gemma":[0.9988286,0.0001271946,0.0001708876,0.0001534273,0.00002204282,0.0001302366,0.0004888326,0.000003714199,0.00007502585],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009338806,"threshold_uncertainty_score":0.04938895,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2016111806","doi":"10.1016/j.clml.2014.12.008","title":"Effects of Ruxolitinib Treatment on Metabolic and Nutritional Parameters in Patients With Myelofibrosis From COMFORT-I","year":2014,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"University of Texas MD Anderson Cancer Center; National Cancer Institute; National Institutes of Health; Incyte; Gilead Sciences; Sanofi; Genentech; Celgene; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Ruxolitinib; Myelofibrosis; Medicine; Placebo; Internal medicine; Clinical endpoint; Gastroenterology; Post-hoc analysis; Randomized controlled trial; Surgery; Bone marrow; Pathology","authors":[{"name":"Ruben A. Mesa","is_ca":false},{"name":"Srđan Verstovšek","is_ca":false},{"name":"Vikas Gupta","is_ca":true},{"name":"John Mascarenhas","is_ca":false},{"name":"Ehab Atallah","is_ca":false},{"name":"Timothy C. Burn","is_ca":false},{"name":"William Sun","is_ca":false},{"name":"Victor Sandor","is_ca":false},{"name":"Jason Gotlib","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01370294947349546,"gpt":0.2692774016353615,"spread":0.255574452161866,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001054846,0.0005375192,0.001474807,0.0002201151,0.000194914,0.0004160831,0.0002958736,0.0004388384,0.001514352],"category_scores_gemma":[0.001008957,0.0001807306,0.0009685396,0.0002252713,0.0003180805,0.0002633229,0.0002223744,0.0008170502,0.0001722283],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003775663,"about_ca_system_score_gemma":0.0004212987,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004996648,"about_ca_topic_score_gemma":0.001952554,"domain_scores_codex":[0.999615,0.0001979199,0.00004362181,0.00004326204,0.00004286124,0.00005729191],"domain_scores_gemma":[0.9995008,0.0001388077,0.0001769135,0.00002132527,0.0000216362,0.0001404695],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.7613868,0.01045309,0.04282364,0.001352935,0.002948254,0.0003835211,0.0001694321,0.001606615,0.02121335,0.0001362231,0.001858869,0.1556674],"study_design_scores_gemma":[0.2411699,0.4953668,0.2489593,0.0002405868,0.002732929,0.001031444,0.0001955693,0.001827742,0.005113282,0.0001780597,0.003118254,0.00006618177],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9955763,0.003392961,0.00005075317,0.00009874412,0.00002682159,0.000109032,0.0001517681,0.00001195967,0.0005817493],"genre_scores_gemma":[0.9982936,0.0007028626,0.0002287375,0.0001751081,0.00004319621,0.0001070181,0.0002641855,0.000001630032,0.0001835763],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001514352,"threshold_uncertainty_score":0.005578578,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2083459234","doi":"10.3816/clml.2010.n.059","title":"Phase II Study of Obatoclax Mesylate (GX15-070), a Small-Molecule BCL-2 Family Antagonist, for Patients With Myelofibrosis","year":2010,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ontario Institute for Cancer Research; Princess Margaret Cancer Centre","funders":"","keywords":"Myelofibrosis; Medicine; Internal medicine; Anemia; Adverse effect; Gastroenterology; Cyclophosphamide; Rash; Surgery; Chemotherapy; Bone marrow","authors":[{"name":"Sameer A. Parikh","is_ca":false},{"name":"Hagop M. Kantarjian","is_ca":false},{"name":"Aaron D. Schimmer","is_ca":true},{"name":"William Walsh","is_ca":false},{"name":"Ekatherine Asatiani","is_ca":false},{"name":"Khaled El‐Shami","is_ca":false},{"name":"Elliott F. Winton","is_ca":false},{"name":"Srđan Verstovšek","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02810113146998339,"gpt":0.3297646416348803,"spread":0.3016635101648969,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000965681,0.001298136,0.001900264,0.0004065047,0.0003651518,0.0007776057,0.0008073174,0.001002053,0.003133422],"category_scores_gemma":[0.0005169865,0.0005172387,0.0008871771,0.0003190092,0.0009026211,0.0006791047,0.0002765642,0.00229697,0.0009059547],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007369386,"about_ca_system_score_gemma":0.001663916,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001545829,"about_ca_topic_score_gemma":0.003676163,"domain_scores_codex":[0.9997501,0.0001187989,0.000009354964,0.00003090486,0.00001984409,0.00007105093],"domain_scores_gemma":[0.9995638,0.00007149175,0.00005130172,0.00002902384,0.00002187723,0.0002624801],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6813905,0.06698391,0.008327911,0.0008805708,0.001517822,0.0004269959,0.0003817352,0.00495685,0.07646431,0.001167395,0.008685769,0.1488163],"study_design_scores_gemma":[0.6679043,0.3116589,0.009683012,0.00003014381,0.0004061835,0.0003213574,0.00006972646,0.001799075,0.004432136,0.0002564847,0.003409246,0.00002938741],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.991971,0.001943538,0.0005124887,0.0006728837,0.0001491271,0.001498431,0.0008308701,0.0001115416,0.002310038],"genre_scores_gemma":[0.9879339,0.001991639,0.001393744,0.001095961,0.0001606627,0.001787052,0.002166367,0.00002885571,0.003441801],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003133422,"threshold_uncertainty_score":0.01048231,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2810788428","doi":"10.1016/j.clml.2018.06.016","title":"Safety Analysis of Four Randomized Controlled Studies of Ibrutinib in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Mantle Cell Lymphoma","year":2018,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"Pharmacyclics","keywords":"Ibrutinib; Medicine; Mantle cell lymphoma; Chronic lymphocytic leukemia; Internal medicine; Adverse effect; Discontinuation; Oncology; Lymphoma; Leukemia","authors":[{"name":"Susan O’Brien","is_ca":false},{"name":"Peter Hillmen","is_ca":false},{"name":"Steven Coutré","is_ca":false},{"name":"Paul M. Barr","is_ca":false},{"name":"Graeme Fraser","is_ca":true},{"name":"Alessandra Tedeschi","is_ca":false},{"name":"Jan A. Burger","is_ca":false},{"name":"Marie‐Sarah Dilhuydy","is_ca":false},{"name":"Georg Heß","is_ca":false},{"name":"Carol Moreno","is_ca":false},{"name":"Paula Cramer","is_ca":false},{"name":"Emily Liu","is_ca":false},{"name":"Stephen Chang","is_ca":false},{"name":"Jessica Vermeulen","is_ca":false},{"name":"Lori Styles","is_ca":false},{"name":"Angela Howes","is_ca":false},{"name":"Danelle F. James","is_ca":false},{"name":"Kalpesh Patel","is_ca":false},{"name":"Thorsten Graef","is_ca":false},{"name":"Rudolph Valentino","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03911592668850494,"gpt":0.3368084978425915,"spread":0.2976925711540866,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00960112,0.001988237,0.004985427,0.001034582,0.0005857375,0.001939922,0.001135442,0.002055263,0.004320514],"category_scores_gemma":[0.01601805,0.0008623415,0.008312169,0.001020803,0.00144296,0.001298359,0.0006805719,0.003088382,0.000342177],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001705709,"about_ca_system_score_gemma":0.001350951,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001131113,"about_ca_topic_score_gemma":0.002059734,"domain_scores_codex":[0.9928582,0.004976529,0.0008233315,0.0005455721,0.000421783,0.0003746669],"domain_scores_gemma":[0.9894966,0.006139577,0.002616399,0.0006949019,0.0006290777,0.0004233713],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.9319754,0.0007721794,0.001661303,0.007077099,0.04254489,0.0001013017,0.00006872766,0.0005205959,0.001351464,0.0001769174,0.0006888821,0.0130613],"study_design_scores_gemma":[0.9374095,0.02094156,0.004341319,0.0004218123,0.03408272,0.00007449897,0.00005695742,0.000449321,0.0005592039,0.0003587925,0.001269175,0.0000352072],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8577286,0.1193878,0.004140578,0.001626863,0.001455298,0.007575276,0.002725553,0.0003653004,0.004994752],"genre_scores_gemma":[0.9826915,0.01066457,0.001345247,0.0009969155,0.000364604,0.002211538,0.0007527391,0.00003387974,0.0009391149],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00960112,"threshold_uncertainty_score":0.05077618,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2047725399","doi":"10.1016/j.clml.2013.03.020","title":"Subcutaneous Omacetaxine Mepesuccinate in Patients With Chronic-Phase Chronic Myeloid Leukemia Previously Treated With 2 or More Tyrosine Kinase Inhibitors Including Imatinib","year":2013,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; University of Texas MD Anderson Cancer Center; Teva Pharmaceutical Industries","keywords":"Medicine; Nilotinib; Dasatinib; Internal medicine; Adverse effect; Gastroenterology; Imatinib; Neutropenia; Clinical endpoint; Confidence interval; Myeloid leukemia; Surgery; Randomized controlled trial; Toxicity","authors":[{"name":"Jörge E. Cortes","is_ca":false},{"name":"Franck E. Nicolini","is_ca":false},{"name":"Meir Wetzler","is_ca":false},{"name":"Jeffrey H. Lipton","is_ca":true},{"name":"Luke P. Akard","is_ca":false},{"name":"Adam Craig","is_ca":false},{"name":"Nisha Nanda","is_ca":false},{"name":"Annie-Claude Benichou","is_ca":false},{"name":"Janis Leonoudakis","is_ca":false},{"name":"H. Jean Khoury","is_ca":false},{"name":"Andreas Hochhaus","is_ca":false},{"name":"Michele Baccarani","is_ca":false},{"name":"Hagop M. Kantarjian","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01974581216089715,"gpt":0.3045457770249775,"spread":0.2847999648640803,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001209564,0.0002227377,0.0003666009,0.0001599536,0.0001965464,0.0001714544,0.0001246319,0.0002446388,0.001181705],"category_scores_gemma":[0.0003424473,0.0000857513,0.000266961,0.0002617188,0.0001815825,0.0002338712,0.0001393476,0.000360838,0.0001225109],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002591083,"about_ca_system_score_gemma":0.0004382503,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00119193,"about_ca_topic_score_gemma":0.004145372,"domain_scores_codex":[0.9999428,0.00001454552,0.00000552349,0.000007138254,0.000009382557,0.00002061124],"domain_scores_gemma":[0.9998994,0.00002077392,0.00002388975,0.000002963335,0.000003230532,0.00004985505],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1278069,0.003721345,0.4953143,0.0006483312,0.000915784,0.01875053,0.0004842467,0.00272094,0.075642,0.0006959612,0.006692551,0.2666071],"study_design_scores_gemma":[0.01565917,0.06160232,0.8775311,0.0001440037,0.0007462982,0.019617,0.0005731338,0.003199181,0.007522154,0.0006239701,0.01273628,0.00004548864],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9948123,0.002248489,0.00008373731,0.0004541327,0.00004652822,0.00003617593,0.0001077364,0.00001154534,0.002199437],"genre_scores_gemma":[0.9986791,0.0007326925,0.00006901036,0.0001325255,0.00003126383,0.00001097627,0.00009741518,0.000001085446,0.0002458014],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00119193,"threshold_uncertainty_score":0.003953159,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2511176690","doi":"10.1016/j.clml.2016.08.010","title":"Myelomatous Involvement of the Central Nervous System","year":2016,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Central nervous system; Multiple myeloma; Cerebrospinal fluid; Odds ratio; Magnetic resonance imaging; Confidence interval; Complication; Bone marrow; Cohort; Plasma cell; Internal medicine; Pathology; Gastroenterology; Radiology","authors":[{"name":"Jonas Paludo","is_ca":false},{"name":"Utkarsh Painuly","is_ca":false},{"name":"Shaji Kumar","is_ca":false},{"name":"Wilson I. Gonsalves","is_ca":false},{"name":"S. Vincent Rajkumar","is_ca":false},{"name":"Francis K. Buadi","is_ca":false},{"name":"Martha Q. Lacy","is_ca":false},{"name":"Angela Dispenzieri","is_ca":false},{"name":"Robert A. Kyle","is_ca":false},{"name":"Michelle L. Mauermann","is_ca":false},{"name":"Arleigh McCurdy","is_ca":true},{"name":"David Dingli","is_ca":false},{"name":"Ronald S. Go","is_ca":false},{"name":"Suzanne R. Hayman","is_ca":false},{"name":"Nelson Leung","is_ca":false},{"name":"John A. Lust","is_ca":false},{"name":"Yi Lin","is_ca":false},{"name":"Morie A. Gertz","is_ca":false},{"name":"Prashant Kapoor","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03741777232020433,"gpt":0.3179641029791642,"spread":0.2805463306589599,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002286579,0.0005411911,0.00034531,0.001588265,0.0009809756,0.0007698936,0.0005471681,0.00051317,0.007433222],"category_scores_gemma":[0.0009741979,0.0001601504,0.0002696215,0.001361345,0.000697795,0.0005102475,0.0006588189,0.0006309939,0.0009745],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008909812,"about_ca_system_score_gemma":0.0009191678,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004713655,"about_ca_topic_score_gemma":0.00749643,"domain_scores_codex":[0.99978,0.00003262634,0.00001913328,0.00004060889,0.00005243417,0.00007514473],"domain_scores_gemma":[0.9995548,0.00008622766,0.0001323702,0.00005397018,0.00008664278,0.00008591238],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001435449,0.0003161221,0.3864134,0.00172107,0.0007213601,0.3348801,0.000691716,0.001342346,0.05086311,0.008683803,0.01418703,0.1987445],"study_design_scores_gemma":[0.0001128513,0.0003456435,0.3270948,0.0003943371,0.0004379585,0.6103195,0.0005270102,0.001353126,0.01864239,0.005213289,0.03551831,0.0000409792],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7284387,0.04522619,0.007030746,0.00217314,0.0003016781,0.0001875894,0.001579973,0.0006342806,0.2144276],"genre_scores_gemma":[0.9903061,0.003889192,0.0007888321,0.0003655543,0.0001309043,0.00001758912,0.0001887817,0.00001580348,0.004297197],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007433222,"threshold_uncertainty_score":0.02486664,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1979590202","doi":"10.3816/clml.2010.n.079","title":"Bendamustine Produces Durable Responses With an Acceptable Safety Profile in Patients With Rituximab-Refractory Indolent Non-Hodgkin Lymphoma","year":2010,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Bendamustine; Medicine; Rituximab; Internal medicine; Refractory (planetary science); Gastroenterology; Salvage therapy; Chronic lymphocytic leukemia; Follicular lymphoma; Chemotherapy; Surgery; Lymphoma; Oncology; Leukemia","authors":[{"name":"Bruce D. Cheson","is_ca":false},{"name":"Jonathan W. Friedberg","is_ca":false},{"name":"Brad S. Kahl","is_ca":false},{"name":"Richard H. van der Jagt","is_ca":true},{"name":"Lothar Tremmel","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01391796457377985,"gpt":0.2928866579376173,"spread":0.2789686933638374,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003509965,0.0002198619,0.0004692392,0.0001363316,0.0001293123,0.0002107572,0.0001662593,0.0001958152,0.001037067],"category_scores_gemma":[0.0005121856,0.0001125657,0.0001979446,0.000203594,0.000142867,0.0002185688,0.00009493263,0.0005757326,0.0002702531],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002741714,"about_ca_system_score_gemma":0.0001473314,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003979348,"about_ca_topic_score_gemma":0.001347879,"domain_scores_codex":[0.9998963,0.00003771343,0.000008456967,0.00001016838,0.00001677956,0.00003050866],"domain_scores_gemma":[0.9998413,0.00006429004,0.00003029768,0.00002041847,0.000008918466,0.00003477779],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.04186015,0.002536005,0.05493111,0.000591663,0.000673635,0.003279144,0.0004211082,0.003860533,0.3479676,0.0004071976,0.004364008,0.5391078],"study_design_scores_gemma":[0.02650407,0.1503637,0.5948517,0.0001358384,0.001079107,0.02690845,0.0004197898,0.006595201,0.1583444,0.0009279753,0.03379711,0.00007273394],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.993813,0.002741633,0.0006694787,0.0002050314,0.00002101783,0.00005332103,0.0001534624,0.00005727215,0.002285821],"genre_scores_gemma":[0.998462,0.0005219969,0.0002369385,0.0001070607,0.00001487313,0.00001420042,0.0002448966,0.000008416022,0.0003896432],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001037067,"threshold_uncertainty_score":0.003469288,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2627091086","doi":"10.1016/j.clml.2017.06.001","title":"Effects of Bosutinib Treatment on Renal Function in Patients With Philadelphia Chromosome-Positive Leukemias","year":2017,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"Pfizer","keywords":"Bosutinib; Renal function; Medicine; Imatinib; Internal medicine; Oncology; Gastroenterology; Dasatinib","authors":[{"name":"Jörge E. Cortes","is_ca":false},{"name":"Carlo Gambacorti‐Passerini","is_ca":false},{"name":"Dong‐Wook Kim","is_ca":false},{"name":"Hagop M. Kantarjian","is_ca":false},{"name":"Jeff H. Lipton","is_ca":true},{"name":"Amit Lahoti","is_ca":false},{"name":"Moshe Talpaz","is_ca":false},{"name":"Ewa Matczak","is_ca":false},{"name":"Elly Barry","is_ca":false},{"name":"Eric Leip","is_ca":false},{"name":"Tim H. Brümmendorf","is_ca":false},{"name":"H. Jean Khoury","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01881039639050934,"gpt":0.2963083973831734,"spread":0.277498000992664,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001195522,0.0002921517,0.0008486944,0.0002521084,0.0002521257,0.0005564325,0.0001707332,0.0001780311,0.001084915],"category_scores_gemma":[0.001596586,0.00008864934,0.0006294727,0.0002886854,0.0001745961,0.0002540084,0.0002160369,0.0006567871,0.0001510451],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003989521,"about_ca_system_score_gemma":0.0004210221,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003596058,"about_ca_topic_score_gemma":0.001012032,"domain_scores_codex":[0.9994565,0.0002363134,0.00005444942,0.00005495309,0.0001039653,0.00009377586],"domain_scores_gemma":[0.998731,0.0003781973,0.0005024303,0.00003257542,0.0001000527,0.0002558307],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.04427315,0.002175783,0.7618144,0.0006223623,0.001210228,0.0006775397,0.0001156763,0.001060396,0.01168686,0.0001330863,0.001580544,0.1746499],"study_design_scores_gemma":[0.004436225,0.04643952,0.9333919,0.0001409499,0.00101725,0.002682814,0.0001686251,0.001440048,0.005477972,0.0001812854,0.004597397,0.00002603023],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9905093,0.007820227,0.00009674274,0.0002406511,0.00002851431,0.00004098885,0.0001709071,0.000008754155,0.001083995],"genre_scores_gemma":[0.9981236,0.00107875,0.000108559,0.0002188578,0.00004669187,0.00002283977,0.0002425799,0.000001710465,0.0001564787],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001195522,"threshold_uncertainty_score":0.006322563,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2069385780","doi":"10.1016/j.clml.2011.03.033","title":"Addition of AEG35156 XIAP Antisense Oligonucleotide in Reinduction Chemotherapy Does Not Improve Remission Rates in Patients With Primary Refractory Acute Myeloid Leukemia in a Randomized Phase II Study","year":2011,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":53,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hôpital Charles-Le Moyne; Université de Montréal; Hôpital Maisonneuve-Rosemont; Aegera Therapeutics (Canada); University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Idarubicin; Cytarabine; Medicine; Chemotherapy; Myeloid leukemia; Internal medicine; Refractory (planetary science); XIAP; Induction chemotherapy; Gastroenterology; Oncology; Randomized controlled trial; Acute leukemia; Leukemia; Pharmacology; Surgery; Apoptosis; Caspase; Biology","authors":[{"name":"Aaron D. Schimmer","is_ca":true},{"name":"Wolfgang Herr","is_ca":false},{"name":"Mathias Hänel","is_ca":false},{"name":"G. Borthakur","is_ca":false},{"name":"Arthur E. Frankel","is_ca":false},{"name":"Heinz‐August Horst","is_ca":false},{"name":"Sonja Martin","is_ca":false},{"name":"Jeannine Kassis","is_ca":true},{"name":"Karen Seiter","is_ca":false},{"name":"Walter Fiedler","is_ca":false},{"name":"Richard Noppeney","is_ca":false},{"name":"Aristoteles Giagounidis","is_ca":false},{"name":"Christine Jacob","is_ca":true},{"name":"Jacques Jolivet","is_ca":true},{"name":"Martin S. Tallman","is_ca":false},{"name":"Steffen Koschmieder","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01252439752775815,"gpt":0.2751546296371883,"spread":0.2626302321094302,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001549719,0.001075177,0.003445221,0.0003623751,0.0003393487,0.000832568,0.0009428159,0.0009600958,0.003240174],"category_scores_gemma":[0.00079463,0.0004548311,0.001264923,0.0005349251,0.00119408,0.0008306452,0.0003220141,0.002878967,0.0004603009],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008992421,"about_ca_system_score_gemma":0.001025256,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00116085,"about_ca_topic_score_gemma":0.002960977,"domain_scores_codex":[0.9994656,0.0002475253,0.0000327842,0.00009888638,0.00003748732,0.0001176801],"domain_scores_gemma":[0.9993364,0.0001827592,0.0001341352,0.0001023819,0.00002521852,0.0002190193],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.877405,0.01671021,0.002939821,0.0004547094,0.001831524,0.00008103417,0.0001023906,0.001657601,0.02738747,0.0002343064,0.001055755,0.07014018],"study_design_scores_gemma":[0.6646832,0.3180034,0.009882765,0.00003166292,0.001108141,0.0001102342,0.00003719818,0.0007384339,0.004107972,0.0001313919,0.001141968,0.00002369806],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9963742,0.001701203,0.0002351037,0.0002126794,0.0001010706,0.0004410463,0.0002648136,0.00004938424,0.0006205151],"genre_scores_gemma":[0.9964652,0.001157736,0.0004464871,0.0002582485,0.00009465686,0.0003599043,0.0004071106,0.00001648445,0.0007940539],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003445221,"threshold_uncertainty_score":0.01083946,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3158356424","doi":"10.1016/j.clml.2021.04.013","title":"Sex Differences in Multiple Myeloma Biology but not Clinical Outcomes: Results from 3894 Patients in the Myeloma XI Trial","year":2021,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Cancer Research","funders":"Institute of Cancer Research; Cancer Research UK; Myeloma UK; National Cancer Research Institute; Celgene; University of Leeds; National Institute for Health and Care Research; Melanoma Research Alliance; Amgen; University of Birmingham; Cancer Research Institute","keywords":"Multiple myeloma; Dyscrasia; Lenalidomide; Incidence (geometry); Internal medicine; Disease; Cancer; Medicine; Oncology; Clinical trial; Plasma cell dyscrasia; Immunology; Plasma cell","authors":[{"name":"Sarah Bird","is_ca":true},{"name":"David A. Cairns","is_ca":false},{"name":"Tom Menzies","is_ca":false},{"name":"Kevin Boyd","is_ca":true},{"name":"Faith E. Davies","is_ca":false},{"name":"Gordon Cook","is_ca":false},{"name":"Mark T. Drayson","is_ca":false},{"name":"Walter M. Gregory","is_ca":false},{"name":"Matthew Jenner","is_ca":false},{"name":"John R Jones","is_ca":true},{"name":"Martin Kaiser","is_ca":true},{"name":"Roger G. Owen","is_ca":false},{"name":"Graham Jackson","is_ca":false},{"name":"Gareth J. Morgan","is_ca":false},{"name":"Charlotte Pawlyn","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1172578914546457,"gpt":0.3878514811505375,"spread":0.2705935896958919,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002520985,0.000442512,0.001385241,0.0001757952,0.0002860882,0.000851113,0.0005321776,0.0007322626,0.003379994],"category_scores_gemma":[0.003324611,0.0001947847,0.001397557,0.0005726975,0.0003201288,0.0004131127,0.0005250651,0.00110332,0.0003855926],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005699481,"about_ca_system_score_gemma":0.000532733,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009890962,"about_ca_topic_score_gemma":0.001589543,"domain_scores_codex":[0.998674,0.0007200862,0.0001112405,0.0001891194,0.0001629102,0.0001426811],"domain_scores_gemma":[0.9976041,0.0006450257,0.001064122,0.0002220351,0.0001036367,0.0003611886],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.6338851,0.002584549,0.2588991,0.001321505,0.01181748,0.0005002564,0.0004469584,0.001704129,0.003425247,0.0002954478,0.008240926,0.07687946],"study_design_scores_gemma":[0.1911941,0.06411151,0.7213749,0.0003401811,0.008741714,0.0008831792,0.0002591779,0.001133216,0.001081678,0.0006848268,0.01009692,0.00009857016],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9903218,0.004997436,0.00008335186,0.0004394188,0.00003956395,0.0001946242,0.002630384,0.00001065618,0.001282784],"genre_scores_gemma":[0.9930999,0.001467992,0.0001939661,0.000547434,0.000103454,0.000338055,0.00297768,0.00001159333,0.001259793],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003379994,"threshold_uncertainty_score":0.01333237,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2725714565","doi":"10.1016/j.clml.2017.06.020","title":"Prognostic Validation of SKY92 and Its Combination With ISS in an Independent Cohort of Patients With Multiple Myeloma","year":2017,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Oncology; Cohort; Multiple myeloma; Hazard ratio; Confidence interval","authors":[{"name":"Erik H. van Beers","is_ca":false},{"name":"Martin H. van Vliet","is_ca":false},{"name":"Rowan Kuiper","is_ca":false},{"name":"Leonie de Best","is_ca":false},{"name":"Kenneth C. Anderson","is_ca":false},{"name":"Ajai Chari","is_ca":false},{"name":"Sundar Jagannath","is_ca":false},{"name":"Andrzej Jakubowiak","is_ca":false},{"name":"Shaji Kumar","is_ca":false},{"name":"Joan Levy","is_ca":false},{"name":"Daniel Auclair","is_ca":false},{"name":"Sagar Lonial","is_ca":false},{"name":"Donna Reece","is_ca":true},{"name":"Paul G. Richardson","is_ca":false},{"name":"David S. Siegel","is_ca":false},{"name":"A. Keith Stewart","is_ca":false},{"name":"Suzanne Trudel","is_ca":true},{"name":"Ravi Vij","is_ca":false},{"name":"Todd M. Zimmerman","is_ca":false},{"name":"Rafaël Fonseca","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03228211966396329,"gpt":0.3341316169356094,"spread":0.3018494972716462,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009156535,0.0005808682,0.000626307,0.001081363,0.0006054432,0.001157403,0.0006200558,0.0006836949,0.001969717],"category_scores_gemma":[0.002257047,0.0002859045,0.0006567774,0.001315841,0.0005522691,0.0007180339,0.0008199677,0.0008086336,0.0007920691],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003457868,"about_ca_system_score_gemma":0.0004580052,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001043063,"about_ca_topic_score_gemma":0.00163735,"domain_scores_codex":[0.9993962,0.0001298463,0.00006448144,0.0001383647,0.0001362973,0.0001347907],"domain_scores_gemma":[0.9987336,0.0002656273,0.000403873,0.0001721449,0.0002112607,0.0002136163],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003815947,0.00002917802,0.9961479,0.000006597015,0.00006023209,0.0001169202,0.00003410141,0.00007159548,0.001305374,0.00002247268,0.0001986775,0.001625435],"study_design_scores_gemma":[0.00003564662,0.0002170004,0.9962548,0.000008086829,0.0001388091,0.001031498,0.000185755,0.000612243,0.0005907757,0.0001082047,0.0008087216,0.000008464086],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9984645,0.0003103879,0.0001249582,0.00007827535,0.0000185235,0.00000588306,0.0004208621,0.000008118807,0.000568472],"genre_scores_gemma":[0.9985256,0.0001022013,0.0001132648,0.0000382961,0.0000524248,0.000008676096,0.0009562756,0.000004361226,0.0001990571],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001969717,"threshold_uncertainty_score":0.006589413,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3003488950","doi":"10.1016/j.clml.2020.01.017","title":"Consensus Guidelines on the Diagnosis of Multiple Myeloma and Related Disorders: Recommendations of the Myeloma Canada Research Network Consensus Guideline Consortium","year":2020,"lang":"en","type":"review","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"University of Alberta; University of British Columbia; Western University; University of Manitoba; London Health Sciences Centre; Vancouver General Hospital; CancerCare Manitoba; Memorial University of Newfoundland","funders":"Memorial University of Newfoundland; Queen's University; Centre Hospitalier Universitaire de Québec; Saskatchewan Cancer Agency","keywords":"Guideline; Multiple myeloma; Consensus conference; Medicine; Family medicine; Intensive care medicine; Pathology; Immunology; Internal medicine","authors":[{"name":"Debra Bergstrom","is_ca":true},{"name":"Rami Kotb","is_ca":true},{"name":"Martha Louzada","is_ca":true},{"name":"Heather J. Sutherland","is_ca":true},{"name":"Sofia Tavoularis","is_ca":false},{"name":"Christopher P. Venner","is_ca":true},{"name":"Julie Anne Côté","is_ca":false},{"name":"Richard LeBlanc","is_ca":false},{"name":"Tony Reiman","is_ca":false},{"name":"Michaël Sébag","is_ca":false},{"name":"Kevin Song","is_ca":false},{"name":"Gabriele Colasurdo","is_ca":false},{"name":"Aldo Del Col","is_ca":false},{"name":"David P. McMullen","is_ca":false},{"name":"Annette E. Hay","is_ca":false},{"name":"Nicole M.B. Laferriere","is_ca":false},{"name":"Arleigh McCurdy","is_ca":false},{"name":"Jean Roy","is_ca":false},{"name":"Julie Stakiw","is_ca":false},{"name":"Suzanne Trudel","is_ca":false},{"name":"Darrell White","is_ca":false},{"name":"Fraser W. Loveys","is_ca":false},{"name":"Edward Randell","is_ca":false},{"name":"Kamilia Rizkalla","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1785388692396007,"gpt":0.438239768301308,"spread":0.2597008990617073,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01699945,0.002105285,0.006616492,0.0120464,0.001685609,0.003888553,0.009508446,0.006754773,0.006156057],"category_scores_gemma":[0.03265085,0.001393733,0.01055645,0.01027962,0.001590456,0.002720565,0.002740137,0.007720324,0.00323758],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01257747,"about_ca_system_score_gemma":0.05846891,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.1194514,"about_ca_topic_score_gemma":0.1463164,"domain_scores_codex":[0.988955,0.003102313,0.003515392,0.0006603796,0.003201387,0.0005655061],"domain_scores_gemma":[0.9739712,0.007754093,0.003400399,0.0003216587,0.01356947,0.0009830978],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004240383,0.0001624809,0.001414064,0.1230816,0.002152357,0.0004013081,0.0004766529,0.0009091949,0.000590921,0.007526745,0.524303,0.3385576],"study_design_scores_gemma":[0.0009495251,0.0001138098,0.005147418,0.2831393,0.007085679,0.000768745,0.0003811308,0.0004233603,0.0003703484,0.005541579,0.6959232,0.0001558946],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000381902,0.9327247,0.003138442,0.04220487,0.005893466,0.001855286,0.005719718,0.000145234,0.007936359],"genre_scores_gemma":[0.003666846,0.9324653,0.02412847,0.02210124,0.001490327,0.002871762,0.00871675,0.00006077981,0.004498502],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9874225,"threshold_uncertainty_score":0.2375122,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1944400929","doi":"10.1016/j.clml.2015.05.007","title":"Pomalidomide and Low-Dose Dexamethasone Improves Health-Related Quality of Life and Prolongs Time to Worsening in Relapsed/Refractory Patients With Multiple Myeloma Enrolled in the MM-003 Randomized Phase III Trial","year":2015,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta; Vancouver General Hospital","funders":"","keywords":"Pomalidomide; Medicine; Dexamethasone; Lenalidomide; Internal medicine; Multiple myeloma; Clinical endpoint; Randomized controlled trial; Refractory (planetary science); Bortezomib; Oncology; Surgery","authors":[{"name":"Katja Weisel","is_ca":false},{"name":"Meletios Α. Dimopoulos","is_ca":false},{"name":"Kevin Song","is_ca":true},{"name":"Philippe Moreau","is_ca":false},{"name":"Antonio Palumbo","is_ca":false},{"name":"Andrew R. Belch","is_ca":true},{"name":"Stephen Schey","is_ca":false},{"name":"Pieter Sonneveld","is_ca":false},{"name":"Lars Sternås","is_ca":false},{"name":"Xin Yu","is_ca":false},{"name":"Ramesh Amatya","is_ca":false},{"name":"Craig J. Gibson","is_ca":false},{"name":"Mohamed H. Zaki","is_ca":false},{"name":"Christian Jacques","is_ca":false},{"name":"Jesús F. San Miguel","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04760729851974062,"gpt":0.3588236787743686,"spread":0.311216380254628,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001266076,0.0008975553,0.001853314,0.0001809867,0.0003418086,0.0009178647,0.000767939,0.00078072,0.003192961],"category_scores_gemma":[0.00111981,0.0003310832,0.002003397,0.0004027299,0.0006459783,0.0006247432,0.0004428964,0.00251543,0.0003789356],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001034048,"about_ca_system_score_gemma":0.001297967,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001615427,"about_ca_topic_score_gemma":0.00480647,"domain_scores_codex":[0.9994876,0.0002742085,0.00003610601,0.000073977,0.00004252235,0.00008556704],"domain_scores_gemma":[0.9993611,0.0001350532,0.000220542,0.0000401342,0.00002086269,0.0002223854],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9575197,0.003850601,0.00441375,0.0003441859,0.002162335,0.00003379376,0.00003547136,0.0006113517,0.002270595,0.0001500837,0.001814198,0.02679393],"study_design_scores_gemma":[0.9074377,0.0630797,0.02455582,0.00006596845,0.00157509,0.00009068613,0.00005549319,0.0008658152,0.0006739154,0.0003735796,0.001197903,0.00002826554],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9933007,0.003138239,0.0001524186,0.0006409864,0.000170407,0.0004140487,0.0008093223,0.00005045977,0.001323513],"genre_scores_gemma":[0.9950303,0.001219415,0.0005344263,0.0007865652,0.000141692,0.0004344451,0.001102888,0.000008766153,0.0007415013],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003192961,"threshold_uncertainty_score":0.01068151,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2961471425","doi":"10.1016/j.clml.2019.07.004","title":"Long-Term Studies Assessing Outcomes of Ibrutinib Therapy in Patients With Del(11q) Chronic Lymphocytic Leukemia","year":2019,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Juravinski Cancer Centre; McMaster University","funders":"Cilag; Janssen Pharmaceuticals; TG Therapeutics; H. Lundbeck A/S; BeiGene; Pharmacyclics; Genentech; Sunesis; Astellas Pharma; Exelixis; Sun Pharma; Regeneron Pharmaceuticals; F. Hoffmann-La Roche; AbbVie; Janssen Biotech; Teva Pharmaceutical Industries; Gilead Sciences; Janssen Research and Development; MorphoSys; Pfizer; Biogen; Celgene; AstraZeneca; Amgen; Alexion Pharmaceuticals; Roche; GlaxoSmithKline","keywords":"Ibrutinib; Medicine; Chronic lymphocytic leukemia; Oncology; Internal medicine; Leukemia","authors":[{"name":"Thomas J. Kipps","is_ca":false},{"name":"Graeme Fraser","is_ca":true},{"name":"Steven Coutré","is_ca":false},{"name":"Jennifer R. Brown","is_ca":false},{"name":"Jacqueline C. Barrientos","is_ca":false},{"name":"Paul M. Barr","is_ca":false},{"name":"John C. Byrd","is_ca":false},{"name":"Susan O’Brien","is_ca":false},{"name":"Marie‐Sarah Dilhuydy","is_ca":false},{"name":"Peter Hillmen","is_ca":false},{"name":"Ulrich Jaeger","is_ca":false},{"name":"Carol Moreno","is_ca":false},{"name":"Paula Cramer","is_ca":false},{"name":"Stephan Stilgenbauer","is_ca":false},{"name":"Asher Chanan‐Khan","is_ca":false},{"name":"Michelle Mahler","is_ca":false},{"name":"Mariya Salman","is_ca":false},{"name":"Karl Eckert","is_ca":false},{"name":"Isabelle G. Solman","is_ca":false},{"name":"Sriram Balasubramanian","is_ca":false},{"name":"Mei Cheng","is_ca":false},{"name":"Anil Londhe","is_ca":false},{"name":"Joi Ninomoto","is_ca":false},{"name":"Angela Howes","is_ca":false},{"name":"Danelle F. James","is_ca":false},{"name":"Michael Hallek","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04643419086277679,"gpt":0.3793727557876246,"spread":0.3329385649248479,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003791232,0.0002999213,0.0006961604,0.0005481787,0.0003893256,0.0007710584,0.0003689618,0.0005099166,0.0007537679],"category_scores_gemma":[0.004950022,0.0001473656,0.0008969107,0.001116599,0.0002802743,0.0005605991,0.000504688,0.0006392782,0.0001212471],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006069552,"about_ca_system_score_gemma":0.0004408353,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001024848,"about_ca_topic_score_gemma":0.002003796,"domain_scores_codex":[0.9987943,0.0004448399,0.0001816853,0.0002369871,0.0001793317,0.0001628543],"domain_scores_gemma":[0.9924448,0.002415425,0.003480886,0.0003180357,0.0006822875,0.0006585345],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.007935439,0.0001229082,0.9764208,0.000152919,0.002304093,0.00009344103,0.00008708741,0.0003036569,0.001106831,0.00001676792,0.0001883184,0.01126773],"study_design_scores_gemma":[0.0002236175,0.003092866,0.9930711,0.00006024842,0.00157087,0.0002619534,0.00008729246,0.0001876238,0.0004521087,0.00003514658,0.0009450593,0.00001217339],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9896498,0.009109971,0.0001627569,0.00008838481,0.00001494461,0.00001993309,0.0005674122,0.000003233429,0.0003835746],"genre_scores_gemma":[0.9976817,0.0008089822,0.00006789254,0.00007618526,0.00004483294,0.00003010705,0.001184144,0.000001852384,0.0001042868],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003791232,"threshold_uncertainty_score":0.02005017,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2023428359","doi":"10.1016/j.clml.2014.12.015","title":"Outcome of Patients With Non-Hodgkin Lymphomas With Concurrent MYC and BCL2 Rearrangements Treated With CODOX-M/IVAC With Rituximab Followed by Hematopoietic Stem Cell Transplantation","year":2015,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Vancouver General Hospital; BC Cancer Agency; University of British Columbia","funders":"Roche","keywords":"Medicine; Internal medicine; Rituximab; Oncology; Plerixafor; Transplantation; Hematopoietic stem cell transplantation; Lymphoma; Autologous stem-cell transplantation; Vincristine; Chemoimmunotherapy; Etoposide; Progression-free survival; Cyclophosphamide; Gastroenterology; Chemotherapy","authors":[{"name":"Haowei Sun","is_ca":true},{"name":"Kerry J. Savage","is_ca":true},{"name":"Aly Karsan","is_ca":true},{"name":"Graham W. Slack","is_ca":true},{"name":"Randy D. Gascoyne","is_ca":true},{"name":"Cynthia L. Toze","is_ca":true},{"name":"Laurie H. Sehn","is_ca":true},{"name":"Yasser Abou Mourad","is_ca":true},{"name":"Michael J. Barnett","is_ca":true},{"name":"Raewyn Broady","is_ca":true},{"name":"Joseph M. Connors","is_ca":true},{"name":"Donna L. Forrest","is_ca":true},{"name":"Alina S. Gerrie","is_ca":true},{"name":"Donna E. Hogge","is_ca":true},{"name":"Sujaatha Narayanan","is_ca":true},{"name":"Thomas J. Nevill","is_ca":true},{"name":"Stephen H. Nantel","is_ca":true},{"name":"Maryse Power","is_ca":true},{"name":"Heather J. Sutherland","is_ca":true},{"name":"Diego Villa","is_ca":true},{"name":"John D. Shepherd","is_ca":true},{"name":"Kevin Song","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02383174685501354,"gpt":0.2816511669996116,"spread":0.257819420144598,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001843144,0.0002028457,0.0004865155,0.000189372,0.000417346,0.0006186567,0.0002190808,0.0004018209,0.001230642],"category_scores_gemma":[0.0006068222,0.0001119333,0.00063016,0.0002628962,0.0002634035,0.0003007055,0.0003166002,0.0005018114,0.0002549894],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005959612,"about_ca_system_score_gemma":0.0003011533,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001572666,"about_ca_topic_score_gemma":0.001694336,"domain_scores_codex":[0.9998304,0.00003261849,0.00001472245,0.00002701959,0.00001745699,0.0000777485],"domain_scores_gemma":[0.9996365,0.00007070146,0.00007937037,0.00001356033,0.00002469938,0.0001752131],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02429917,0.001300515,0.9213007,0.00009496994,0.0005695409,0.01173498,0.0003464536,0.002025659,0.005549134,0.0003030474,0.001335422,0.03114031],"study_design_scores_gemma":[0.0009645409,0.0127491,0.9658771,0.00004617802,0.0006407769,0.01457184,0.0003999405,0.00161375,0.0009505312,0.0003239501,0.001823121,0.00003919574],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9977674,0.0006645102,0.00008231835,0.00007460527,0.00001671397,0.00001074769,0.0001264673,0.000004451463,0.001252757],"genre_scores_gemma":[0.9991793,0.0001465481,0.00002134032,0.00006375345,0.00002812198,0.000005793599,0.0003371059,0.000001837617,0.0002162168],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001572666,"threshold_uncertainty_score":0.004324019,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1975530543","doi":"10.1016/j.clml.2012.05.005","title":"A Phase I Study of the Metal Ionophore Clioquinol in Patients With Advanced Hematologic Malignancies","year":2012,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Clioquinol; Pharmacology; Medicine; Pharmacodynamics; Refractory (planetary science); Drug; Pharmacokinetics; Internal medicine; Biology","authors":[{"name":"Aaron D. Schimmer","is_ca":true},{"name":"Yulia Jitkova","is_ca":true},{"name":"Marcela Gronda","is_ca":true},{"name":"Zezhou Wang","is_ca":true},{"name":"Joseph Brandwein","is_ca":true},{"name":"Christine Chen","is_ca":true},{"name":"Vikas Gupta","is_ca":true},{"name":"Andre C. Schuh","is_ca":true},{"name":"Karen Yee","is_ca":true},{"name":"Jian Chen","is_ca":false},{"name":"Suzanne Ackloo","is_ca":false},{"name":"Tristan D. Booth","is_ca":false},{"name":"Sharon Keays","is_ca":false},{"name":"Mark D. Minden","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02113997822657017,"gpt":0.2970695218787753,"spread":0.2759295436522052,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009459151,0.0008479915,0.001738601,0.000355627,0.0004340703,0.0007061627,0.0008626834,0.001033986,0.002337649],"category_scores_gemma":[0.0006034775,0.0003752599,0.001002005,0.0003802401,0.0009430625,0.0005813404,0.0002989162,0.002586221,0.0005072916],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009256962,"about_ca_system_score_gemma":0.001111647,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002089859,"about_ca_topic_score_gemma":0.003871993,"domain_scores_codex":[0.9996772,0.000153381,0.00000999992,0.00005479094,0.00002169198,0.00008295932],"domain_scores_gemma":[0.9995223,0.0001151172,0.00005577118,0.00004702203,0.00003692315,0.0002227834],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6088532,0.08989304,0.01045726,0.001085581,0.001524811,0.0005374819,0.0007269068,0.004097167,0.1212488,0.0007543677,0.007364264,0.1534573],"study_design_scores_gemma":[0.4454181,0.531248,0.008956999,0.00003786345,0.0005070472,0.0003778725,0.0001481823,0.001056009,0.006981125,0.0002481634,0.004985503,0.00003519991],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9925568,0.002460663,0.0005976935,0.0007657418,0.0001056772,0.001255842,0.0005102658,0.00008299324,0.00166433],"genre_scores_gemma":[0.9934816,0.001802836,0.0008536242,0.0007560867,0.0001043912,0.0008132016,0.0008715062,0.0000234764,0.001293389],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002337649,"threshold_uncertainty_score":0.007820189,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2806039308","doi":"10.1016/j.clml.2018.05.022","title":"An Open-label, Phase II Trial of Entospletinib (GS-9973), a Selective Spleen Tyrosine Kinase Inhibitor, in Diffuse Large B-cell Lymphoma","year":2018,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"National Cancer Institute; Gilead Sciences","keywords":"Medicine; Internal medicine; Gastroenterology; Peripheral edema; Anemia; Hypoalbuminemia; Adverse effect; Leukopenia; Hyponatremia; Surgery; Chemotherapy","authors":[{"name":"John M. Burke","is_ca":false},{"name":"Andrei R. Shustov","is_ca":false},{"name":"James Essell","is_ca":false},{"name":"Dipti Patel‐Donnelly","is_ca":false},{"name":"Jay Yang","is_ca":false},{"name":"Robert Chen","is_ca":false},{"name":"Wei Ye","is_ca":false},{"name":"Wen Shi","is_ca":false},{"name":"Sarit Assouline","is_ca":true},{"name":"Jeff P. Sharman","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0460260974443202,"gpt":0.3835334315622945,"spread":0.3375073341179743,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001407813,0.001571388,0.001460214,0.0003101891,0.0003532114,0.0008930461,0.0009524422,0.001156098,0.003989026],"category_scores_gemma":[0.0007375919,0.0004401808,0.0007666715,0.0003281081,0.0009605487,0.0009531103,0.000306138,0.002740773,0.0009738852],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008737805,"about_ca_system_score_gemma":0.001169653,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008044361,"about_ca_topic_score_gemma":0.002473907,"domain_scores_codex":[0.9996096,0.000199562,0.00001906213,0.0000697442,0.00003457511,0.00006739203],"domain_scores_gemma":[0.9993437,0.0001204946,0.0001248221,0.00005165998,0.00004369649,0.0003155444],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8468474,0.06084846,0.003564799,0.0007706519,0.001124522,0.0003124444,0.0002448887,0.001524083,0.02710067,0.0002096575,0.002525284,0.05492716],"study_design_scores_gemma":[0.7433494,0.245575,0.006381615,0.0000240959,0.0002523489,0.000243906,0.00005829331,0.0009709481,0.001793125,0.0001182816,0.001215993,0.00001688932],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9950901,0.001316352,0.0004002468,0.0002261304,0.00008318682,0.001158776,0.0006090827,0.00005425339,0.001061763],"genre_scores_gemma":[0.9936885,0.0009944832,0.0007895933,0.00047703,0.000127989,0.001057123,0.00157826,0.00001618276,0.001270943],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003989026,"threshold_uncertainty_score":0.01334459,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2410851753","doi":"10.1016/j.clml.2016.06.001","title":"Revised International Staging System Applied to Real World Multiple Myeloma Patients","year":2016,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Alberta Health Services; Calgary Laboratory Services","funders":"","keywords":"Medicine; Multiple myeloma; Staging system; Real world data; Oncology; Internal medicine; Cancer; Data science","authors":[{"name":"Víctor H. Jiménez‐Zepeda","is_ca":false},{"name":"Peter Duggan","is_ca":false},{"name":"Paola Neri","is_ca":false},{"name":"Fariborz Rashid-Kolvear","is_ca":true},{"name":"Jason Tay","is_ca":false},{"name":"Nizar J. Bahlis","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03628137295759545,"gpt":0.3403525894437358,"spread":0.3040712164861404,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001255931,0.0007252863,0.0005946732,0.002203431,0.0004553604,0.0009891,0.0007352578,0.0003056565,0.003585193],"category_scores_gemma":[0.002622503,0.0001730652,0.001049533,0.001870973,0.0002780906,0.0005264763,0.00081466,0.0006274795,0.001064696],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001281986,"about_ca_system_score_gemma":0.001428911,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01530262,"about_ca_topic_score_gemma":0.01899691,"domain_scores_codex":[0.9995166,0.0001285689,0.0001040056,0.00007728335,0.00009644816,0.00007711976],"domain_scores_gemma":[0.999222,0.0001167711,0.0001566884,0.00007018278,0.0003706839,0.00006368272],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001270276,0.00009646218,0.6741408,0.0007695754,0.0007412426,0.0007865517,0.0006548853,0.009910833,0.005749543,0.002824749,0.07013246,0.2329226],"study_design_scores_gemma":[0.0002504581,0.0005779562,0.8765311,0.0003432523,0.001300783,0.00475507,0.0009499607,0.02371435,0.003269867,0.002893741,0.08530805,0.000105566],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7353529,0.01682305,0.08186878,0.002997428,0.001749069,0.002520132,0.07174814,0.002563515,0.08437689],"genre_scores_gemma":[0.9116896,0.002882017,0.04998897,0.0003511829,0.0001163092,0.001059688,0.02540422,0.0001992376,0.008308856],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01530262,"threshold_uncertainty_score":0.0304271,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2523708385","doi":"10.1016/j.clml.2016.08.006","title":"An Evaluation of Treatment Patterns and Outcomes in Elderly Patients Newly Diagnosed With Acute Myeloid Leukemia: A Retrospective Analysis of Electronic Medical Records From US Community Oncology Practices","year":2016,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Group for Research in Decision Analysis","funders":"National Comprehensive Cancer Network; Takeda Oncology; Takeda Pharmaceutical Company","keywords":"Medicine; Internal medicine; Retrospective cohort study; Myeloid leukemia; Medical record; Cancer; Cohort; Pediatrics","authors":[{"name":"Esprit Ma","is_ca":false},{"name":"Vijayveer Bonthapally","is_ca":false},{"name":"Anita Chawla","is_ca":false},{"name":"Patrick Lefèbvre","is_ca":true},{"name":"Ronan Swords","is_ca":false},{"name":"Marie-Hélène Lafeuille","is_ca":false},{"name":"Jonathan Fortier","is_ca":false},{"name":"Bruno Émond","is_ca":false},{"name":"Mei Sheng Duh","is_ca":false},{"name":"Bruce J. Dezube","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04286069260701756,"gpt":0.3989409932947389,"spread":0.3560803006877213,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001234893,0.0002587916,0.0005357121,0.002596323,0.0006883122,0.001087896,0.0004920156,0.0005044434,0.0009737422],"category_scores_gemma":[0.005179929,0.0003338671,0.0006573717,0.005061026,0.0003683585,0.001297911,0.001060223,0.0004087234,0.0001652135],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008198133,"about_ca_system_score_gemma":0.000913659,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01447098,"about_ca_topic_score_gemma":0.02067,"domain_scores_codex":[0.9982107,0.0004146865,0.0004837448,0.0003602203,0.0003113626,0.0002192781],"domain_scores_gemma":[0.9940253,0.001062064,0.003613084,0.0002785957,0.0005919132,0.0004289441],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00003290494,0.00001034363,0.9994913,0.000006362098,0.00003531013,0.00002073914,0.00005289045,0.000008651686,0.00002857798,0.00000492961,0.00002982645,0.0002782134],"study_design_scores_gemma":[0.000005338022,0.00004979227,0.9988108,0.000009432908,0.00003413463,0.0001689891,0.0006392555,0.0001059681,0.0000344274,0.00000850098,0.0001302078,0.00000302939],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9984491,0.0003076988,0.00005109216,0.00003172336,0.000002748277,0.00001119547,0.0009458273,0.000002146947,0.0001983807],"genre_scores_gemma":[0.9984961,0.0001649992,0.00009442359,0.00003722999,0.000006592442,0.00001459409,0.001129804,0.0000019124,0.00005434343],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01447098,"threshold_uncertainty_score":0.02877355,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1975539073","doi":"10.3816/clml.2011.n.005","title":"Efficacy and Safety of Pegylated Liposomal Doxorubicin in Combination With Bortezomib for Multiple Myeloma: Effects of Adverse Prognostic Factors on Outcome","year":2011,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Leukemia & Lymphoma Society of Canada","funders":"","keywords":"Bortezomib; Medicine; Multiple myeloma; Internal medicine; Regimen; Adverse effect; Oncology; Refractory (planetary science); Thalidomide; Population","authors":[{"name":"Joan Bladé","is_ca":false},{"name":"Pieter Sonneveld","is_ca":false},{"name":"Jesús F. San Miguel","is_ca":false},{"name":"Heather J. Sutherland","is_ca":true},{"name":"Roman Hájek","is_ca":false},{"name":"Arnon Nagler","is_ca":false},{"name":"Andrew Spencer","is_ca":false},{"name":"Tadeusz Robak","is_ca":false},{"name":"Keith C. Lantz","is_ca":false},{"name":"Sen Hong Zhuang","is_ca":false},{"name":"Jean‐Luc Harousseau","is_ca":false},{"name":"Robert Z. Orlowski","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04915552958730707,"gpt":0.3304564149059167,"spread":0.2813008853186096,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001240532,0.000564123,0.001456605,0.0003993471,0.0002221264,0.0005684177,0.0004133092,0.0006143355,0.001160923],"category_scores_gemma":[0.001887042,0.0002435979,0.0008676821,0.0004243353,0.0005144699,0.0007865686,0.0002685253,0.001439659,0.0002624749],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000770939,"about_ca_system_score_gemma":0.0005840314,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004280587,"about_ca_topic_score_gemma":0.0006842209,"domain_scores_codex":[0.9994901,0.0002456215,0.00004074435,0.00006877654,0.00006973786,0.0000850302],"domain_scores_gemma":[0.9987755,0.0004391042,0.0003370452,0.0001290575,0.0000425958,0.0002765798],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.6698877,0.007762066,0.04338559,0.0003593402,0.002224555,0.0003495372,0.0001585454,0.003230631,0.03398157,0.00027625,0.0009724403,0.2374117],"study_design_scores_gemma":[0.1249989,0.5376845,0.2859083,0.0001499811,0.004583432,0.001921035,0.000208606,0.009557471,0.02867975,0.001002383,0.005148795,0.0001568083],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9951185,0.003730637,0.0001844005,0.0001982032,0.00005090338,0.00003912102,0.0001233485,0.00001728145,0.0005376149],"genre_scores_gemma":[0.9987721,0.000627206,0.00009656824,0.00007221661,0.00007796683,0.00002690597,0.000134418,0.000005896349,0.0001867183],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001456605,"threshold_uncertainty_score":0.006560683,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2105740844","doi":"10.3816/clml.2010.n.078","title":"Outcome of Patients With IgD and IgM Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation: A Retrospective CIBMTR Study","year":2010,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital; University Health Network","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; National Institute of Allergy and Infectious Diseases; V Foundation for Cancer Research; American Cancer Society","keywords":"Medicine; Immunoglobulin D; Multiple myeloma; Hematopoietic stem cell transplantation; Transplantation; Internal medicine; Oncology; Myeloma protein; Bone marrow; Antibody; Immunology; B cell","authors":[{"name":"Donna Reece","is_ca":true},{"name":"David H. Vesole","is_ca":false},{"name":"Smriti Shrestha","is_ca":false},{"name":"Mei-Jie Zhang","is_ca":false},{"name":"Waleska S. Pérez","is_ca":false},{"name":"Angela Dispenzieri","is_ca":false},{"name":"Giuseppe Milone","is_ca":false},{"name":"Muneer H. Abidi","is_ca":false},{"name":"Harold Atkins","is_ca":true},{"name":"Asad Bashey","is_ca":false},{"name":"Christopher Bredeson","is_ca":false},{"name":"Willem Buján Boza","is_ca":false},{"name":"César O. Freytes","is_ca":false},{"name":"Robert Peter Gale","is_ca":false},{"name":"James Gajewski","is_ca":false},{"name":"John Gibson","is_ca":false},{"name":"Gregory A. Hale","is_ca":false},{"name":"Shaji Kumar","is_ca":false},{"name":"Robert A. Kyle","is_ca":false},{"name":"Hillard M. Lazarus","is_ca":false},{"name":"Philip L. McCarthy","is_ca":false},{"name":"S Pavlovsky","is_ca":false},{"name":"Vivek Roy","is_ca":false},{"name":"Daniel J. Weisdorf","is_ca":false},{"name":"Peter H. Wiernik","is_ca":false},{"name":"Parameswaran Hari","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02449255352773468,"gpt":0.3122991664099886,"spread":0.287806612882254,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004905094,0.0004079607,0.0005773203,0.001076291,0.0007767925,0.0008690722,0.0004196491,0.0005912362,0.001830618],"category_scores_gemma":[0.001160834,0.0003501688,0.000720791,0.001392245,0.0005930261,0.0008067891,0.0007755554,0.0006433345,0.0004504068],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005564969,"about_ca_system_score_gemma":0.000482386,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003715647,"about_ca_topic_score_gemma":0.002139405,"domain_scores_codex":[0.9994944,0.00009484091,0.00006459081,0.0001317487,0.00007089179,0.0001435388],"domain_scores_gemma":[0.9989685,0.0001420676,0.0003791318,0.0001036449,0.0001114994,0.0002951243],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0006547417,0.00007869982,0.9975593,0.000006484493,0.00005684473,0.0004015217,0.00008275034,0.00004641776,0.0003726849,0.00002647158,0.0000506208,0.000663315],"study_design_scores_gemma":[0.00003278801,0.0005986347,0.9965807,0.000003989026,0.00007925982,0.001767603,0.000418362,0.0001116038,0.0001274358,0.00003667691,0.0002327743,0.0000101713],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.999256,0.0001321116,0.00003183329,0.00001137573,0.00000281356,0.00000570217,0.0002186759,0.000001499636,0.0003400103],"genre_scores_gemma":[0.9992952,0.00007220732,0.00002000913,0.00001776461,0.000009921092,0.000005680586,0.0004733239,0.000001574487,0.0001042953],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003715647,"threshold_uncertainty_score":0.007387996,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2735666722","doi":"10.1016/j.clml.2017.07.006","title":"Cardiovascular Events After Exposure to Nilotinib in Chronic Myeloid Leukemia: Long-term Follow-up","year":2017,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; Toronto General Hospital; University of Toronto; University Health Network","funders":"","keywords":"Nilotinib; Myeloid leukemia; Medicine; Chronic myeloid leukaemia; Term (time); Internal medicine; Oncology; Imatinib","authors":[{"name":"Nazanin Aghel","is_ca":true},{"name":"Jeffrey H. Lipton","is_ca":true},{"name":"Eshetu G. Atenafu","is_ca":true},{"name":"Dennis Dong Hwan Kim","is_ca":true},{"name":"Diego Delgado","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03357943388702309,"gpt":0.3265050216853549,"spread":0.2929255877983319,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007609504,0.0004046406,0.00078218,0.0009081742,0.0006308916,0.001033155,0.0004737703,0.0009482861,0.001035871],"category_scores_gemma":[0.001686568,0.0002438931,0.001379532,0.001448876,0.0003288409,0.001105055,0.0006494091,0.001331882,0.0002964491],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005997622,"about_ca_system_score_gemma":0.0005231555,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005254772,"about_ca_topic_score_gemma":0.006522184,"domain_scores_codex":[0.9993712,0.0001050263,0.0000755916,0.0001399786,0.0001199293,0.0001881334],"domain_scores_gemma":[0.9983959,0.0001934558,0.000694463,0.0001321888,0.0002149551,0.0003690077],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001628996,0.0001438624,0.9923447,0.00002615012,0.0004311092,0.0004975094,0.00005472809,0.0001344302,0.0002938294,0.0000263319,0.000231647,0.004186647],"study_design_scores_gemma":[0.00002596653,0.0002971423,0.9984957,0.000009214828,0.0002040491,0.0003122366,0.00009633899,0.0001450784,0.00007493099,0.00004187647,0.0002851157,0.00001241215],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.995618,0.001880966,0.0001477645,0.0001443061,0.00003608342,0.00001959594,0.001084552,0.00001151883,0.001057278],"genre_scores_gemma":[0.9970342,0.0004966139,0.00004693885,0.00008536824,0.00005749911,0.00001460141,0.001766592,0.000002543555,0.0004956533],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005254772,"threshold_uncertainty_score":0.0104484,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2283642020","doi":"10.1016/j.clml.2016.02.002","title":"Evaluating the Impact of a Switch to Nilotinib on Imatinib-Related Chronic Low-Grade Adverse Events in Patients With CML-CP: The ENRICH Study","year":2016,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal; University of Toronto; Princess Margaret Cancer Centre","funders":"National Cancer Institute; University of Texas MD Anderson Cancer Center; Novartis Pharmaceuticals Corporation","keywords":"Nilotinib; Medicine; Imatinib; Adverse effect; Chronic myeloid leukaemia; Oncology; Internal medicine; Myeloid leukemia","authors":[{"name":"Jörge E. Cortes","is_ca":false},{"name":"Jeffrey H. Lipton","is_ca":true},{"name":"Carole B. Miller","is_ca":false},{"name":"Lambert Busque","is_ca":true},{"name":"Luke P. Akard","is_ca":false},{"name":"Javier Pinilla‐Ibarz","is_ca":false},{"name":"Christopher Hunt Keir","is_ca":false},{"name":"Ghulam Warsi","is_ca":false},{"name":"Felice P. Lin","is_ca":false},{"name":"Michael J. Mauro","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03791484173415468,"gpt":0.3841168110887788,"spread":0.3462019693546242,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003563921,0.0005945346,0.0009998521,0.0002140508,0.0002338527,0.000657638,0.0003919876,0.0005293452,0.001847015],"category_scores_gemma":[0.003139108,0.0001755182,0.001465513,0.0002806042,0.0003320283,0.0006289099,0.0006131671,0.0009429227,0.0002470969],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007007248,"about_ca_system_score_gemma":0.0009673135,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006566854,"about_ca_topic_score_gemma":0.001615554,"domain_scores_codex":[0.9988037,0.0006673168,0.0001085436,0.0001576855,0.00014797,0.0001147024],"domain_scores_gemma":[0.9973187,0.0008690665,0.0009145483,0.0001969618,0.0001726084,0.0005282052],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.5712645,0.01156579,0.2703405,0.0007628293,0.00562063,0.0001470056,0.0002188532,0.002774838,0.005179226,0.0001911082,0.001854854,0.1300799],"study_design_scores_gemma":[0.1058366,0.3444406,0.5328054,0.0001419181,0.005134864,0.0003351507,0.0002617441,0.003128035,0.002943855,0.0002651677,0.004619166,0.0000875647],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9976482,0.0008720266,0.00008892588,0.0001273485,0.00001257966,0.0001656118,0.0004517573,0.000007751568,0.0006257708],"genre_scores_gemma":[0.9974892,0.0004159666,0.0003248446,0.0002329997,0.00005023033,0.0002236261,0.001037399,0.000003009612,0.0002226613],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003563921,"threshold_uncertainty_score":0.01884806,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3087469327","doi":"10.1016/j.clml.2020.08.022","title":"Can Next-Generation PI3K Inhibitors Unlock the Full Potential of the Class in Patients With B-Cell Lymphoma?","year":2020,"lang":"en","type":"review","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Janssen Biotech; AstraZeneca France; Servier; Incyte; AbbVie; Genentech; Bayer; Celgene; Bristol-Myers Squibb Canada; Gilead Sciences; Novartis; Roche","keywords":"Medicine; Idelalisib; Follicular lymphoma; Adverse effect; Oncology; PI3K/AKT/mTOR pathway; Clinical trial; Lymphoma; Targeted therapy; Internal medicine; Population; Cancer; Chronic lymphocytic leukemia; Ibrutinib; Leukemia","authors":[{"name":"Tycel Phillips","is_ca":false},{"name":"Jean‐Marie Michot","is_ca":false},{"name":"Vincent Ribrag","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05178835764682573,"gpt":0.3197734926016962,"spread":0.2679851349548705,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008660462,0.0007118247,0.002019307,0.0009531965,0.0002127437,0.001166148,0.001170428,0.001065667,0.00714563],"category_scores_gemma":[0.001012633,0.0002284949,0.001008853,0.0008963631,0.0003531766,0.001567874,0.0007214755,0.002803298,0.002713562],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006413284,"about_ca_system_score_gemma":0.001097761,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001227466,"about_ca_topic_score_gemma":0.004311915,"domain_scores_codex":[0.9998065,0.00004031547,0.00002414345,0.00003171243,0.00006458498,0.00003268095],"domain_scores_gemma":[0.9997025,0.0001500041,0.00004204448,0.000006529498,0.00006725229,0.00003163959],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002761685,0.00005645754,0.0001393166,0.009887921,0.0002002476,0.00007947384,0.00002103629,0.0001955695,0.0005678372,0.002742865,0.04039388,0.9454392],"study_design_scores_gemma":[0.0004035862,0.0002557298,0.0008531691,0.006497774,0.0004474287,0.0005510019,0.00004818043,0.000139347,0.0002242418,0.003407226,0.9871466,0.00002580396],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001120043,0.9979286,0.00006723893,0.0007925051,0.0003511395,0.000005314344,0.00003124027,0.000009550798,0.0007023905],"genre_scores_gemma":[0.0009449816,0.9966468,0.0001491608,0.001231476,0.0002984708,0.00001046715,0.00007675356,0.000002404821,0.000639462],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00714563,"threshold_uncertainty_score":0.02390456,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3087419444","doi":"10.1016/j.clml.2020.09.003","title":"Quality of Life Effect of the Anti-CCR4 Monoclonal Antibody Mogamulizumab Versus Vorinostat in Patients With Cutaneous T-cell Lymphoma","year":2020,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Janssen Biotech; National Cancer Institute; Eisai Incorporated; National Institutes of Health; Galderma; Kyowa Hakko Kirin; Kyowa Kirin Pharmaceutical Development; Manitoba Beekeepers' Association; Portola Pharmaceuticals; Celgene; Takeda Pharmaceuticals U.S.A.; Novartis; Helsinn Therapeutics; Merck","keywords":"Medicine; Vorinostat; Monoclonal antibody; Monoclonal; Lymphoma; Oncology; Cancer research; Antibody; Internal medicine; Immunology","authors":[{"name":"Pierluigi Porcu","is_ca":false},{"name":"Stacie Hudgens","is_ca":false},{"name":"Sarah McCue Horwitz","is_ca":false},{"name":"Pietro Quaglino","is_ca":false},{"name":"Richard Cowan","is_ca":false},{"name":"Larisa J. Geskin","is_ca":false},{"name":"M. Beylot‐Barry","is_ca":false},{"name":"Lysbeth Floden","is_ca":false},{"name":"M. Bagot","is_ca":false},{"name":"Athanasios Tsianakas","is_ca":false},{"name":"Alison J. Moskowitz","is_ca":false},{"name":"Auris Huen","is_ca":false},{"name":"Brigitte Dréno","is_ca":false},{"name":"Stéphane Dalle","is_ca":false},{"name":"Dolores Caballero","is_ca":false},{"name":"Mollie Leoni","is_ca":false},{"name":"Stephen Dale","is_ca":false},{"name":"Fiona Herr","is_ca":false},{"name":"Madeleine Duvic","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03388055340965346,"gpt":0.3475230672563919,"spread":0.3136425138467384,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00210325,0.0003749284,0.001360979,0.000231455,0.0002344439,0.0006203345,0.00030431,0.000436486,0.001391184],"category_scores_gemma":[0.002740935,0.0001965178,0.001503378,0.000219617,0.0002901628,0.0004424196,0.0002918892,0.0008546611,0.0001207321],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007162863,"about_ca_system_score_gemma":0.0005192279,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005193405,"about_ca_topic_score_gemma":0.0009115118,"domain_scores_codex":[0.9991708,0.0005393728,0.00006158523,0.00007566175,0.00006852655,0.00008416332],"domain_scores_gemma":[0.9987068,0.0004797032,0.0003825157,0.0000473192,0.00005636792,0.0003272797],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7255212,0.01243096,0.07642795,0.0006864613,0.004506921,0.0001143492,0.0002514163,0.004408758,0.007794851,0.0001698597,0.001101816,0.1665855],"study_design_scores_gemma":[0.1615256,0.5210561,0.2973753,0.0001543091,0.004389332,0.0003209978,0.0002067323,0.009823644,0.002960438,0.0003779243,0.001759517,0.00005011376],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9973521,0.002048118,0.00007522379,0.0001262701,0.00002879455,0.00006839028,0.00006246204,0.000007818124,0.0002309211],"genre_scores_gemma":[0.9993162,0.0002284649,0.0001277222,0.00008469712,0.00002154671,0.00008718774,0.00006518519,0.000001176157,0.00006782571],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00210325,"threshold_uncertainty_score":0.01112318,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1751193725","doi":"10.1016/j.clml.2015.06.004","title":"Central Nervous System Complications and Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation","year":2015,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Neurological Complications and Syndromes","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Canadian Nuclear Safety Commission","keywords":"Medicine; Hazard ratio; Hematopoietic stem cell transplantation; Retrospective cohort study; Cumulative incidence; Incidence (geometry); Internal medicine; Transplantation; Confidence interval; Surgery","authors":[{"name":"Vijaya Raj Bhatt","is_ca":false},{"name":"Vamshi Balasetti","is_ca":false},{"name":"Jagar Jasem","is_ca":false},{"name":"Smith Giri","is_ca":false},{"name":"Jamés O. Armitage","is_ca":false},{"name":"Fausto R. Loberiza","is_ca":false},{"name":"R. Gregory Bociek","is_ca":false},{"name":"Philip J. Bierman","is_ca":false},{"name":"Lori J. Maness","is_ca":false},{"name":"Julie M. Vose","is_ca":false},{"name":"Pierre Fayad","is_ca":false},{"name":"Mojtaba Akhtari","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04753207381242587,"gpt":0.3070498538989017,"spread":0.2595177800864759,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004265708,0.0001644617,0.0002574177,0.0005389577,0.0004863611,0.0009418983,0.0003256562,0.0003693808,0.002182245],"category_scores_gemma":[0.002798211,0.00008724895,0.0004361963,0.0009228108,0.0004426984,0.0005771721,0.0008286787,0.0007803273,0.0002018321],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006760393,"about_ca_system_score_gemma":0.0007113066,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005013763,"about_ca_topic_score_gemma":0.008499734,"domain_scores_codex":[0.9995919,0.00008192939,0.00004306852,0.00003795875,0.00007735229,0.0001678903],"domain_scores_gemma":[0.998168,0.0002857218,0.0008668879,0.00004499412,0.0001230699,0.0005113478],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004916314,0.0001021934,0.9916815,0.00001366956,0.0001245865,0.0008501624,0.00008723408,0.0001250969,0.0001183948,0.00008829033,0.0003593963,0.005957896],"study_design_scores_gemma":[0.00001702676,0.0001905826,0.997246,0.00002304187,0.00006767538,0.00146737,0.0003517632,0.00009587804,0.00005852083,0.0001912599,0.0002834562,0.000007384428],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966875,0.00091203,0.00003730007,0.0001379103,0.00001858455,0.000004217051,0.0001781407,0.000002236457,0.002022219],"genre_scores_gemma":[0.9991134,0.0003082605,0.00001280529,0.00006504801,0.0000256674,0.000002908421,0.0002772201,0.000001002981,0.0001936508],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005013763,"threshold_uncertainty_score":0.009969175,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2970731184","doi":"10.1016/j.clml.2019.08.004","title":"Comparison of Time to Next Treatment, Health Care Resource Utilization, and Costs in Patients with Chronic Lymphocytic Leukemia Initiated on Front-line Ibrutinib or Chemoimmunotherapy","year":2019,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Group for Research in Decision Analysis","funders":"National Cancer Institute; Janssen Scientific Affairs; Sunesis; AbbVie; BeiGene; TG Therapeutics","keywords":"Medicine; Chemoimmunotherapy; Ibrutinib; Hazard ratio; Internal medicine; Ofatumumab; Rituximab; Chronic lymphocytic leukemia; Oncology; Leukemia; Confidence interval; Lymphoma","authors":[{"name":"Bruno Émond","is_ca":true},{"name":"Murali Sundaram","is_ca":false},{"name":"Hela Romdhani","is_ca":true},{"name":"Patrick Lefèbvre","is_ca":true},{"name":"Song Wang","is_ca":false},{"name":"Anthony R. Mato","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07058158062732924,"gpt":0.3954478741314718,"spread":0.3248662935041426,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003492261,0.0002102785,0.0005102803,0.0004947954,0.0002982694,0.0008117642,0.0002944489,0.0004351933,0.001966199],"category_scores_gemma":[0.001680063,0.0001447936,0.001143075,0.0009818419,0.0001511066,0.0005530912,0.00040471,0.0005797824,0.0001240615],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001310774,"about_ca_system_score_gemma":0.0005824038,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01029386,"about_ca_topic_score_gemma":0.01123262,"domain_scores_codex":[0.9996181,0.00009530019,0.0000421269,0.00005642764,0.00004191163,0.0001460289],"domain_scores_gemma":[0.9990717,0.0002984088,0.0003258111,0.00002337552,0.00005989569,0.0002206961],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.008765148,0.0003401319,0.9816165,0.00005627972,0.000729381,0.0001383464,0.00009695549,0.0008847059,0.0003170854,0.00008929786,0.0004037118,0.006562427],"study_design_scores_gemma":[0.0002236377,0.001314149,0.9956808,0.00002372659,0.0003363404,0.000162705,0.000400977,0.001289931,0.00009136757,0.00007677634,0.0003869294,0.00001260393],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9987066,0.0003349153,0.00001695901,0.00004888248,0.000006279734,0.000005864469,0.0004811892,0.000001113681,0.0003982611],"genre_scores_gemma":[0.999012,0.0001237714,0.00002113036,0.00003134388,0.000009145943,0.000008232892,0.00068747,8.138819e-7,0.0001060892],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01029386,"threshold_uncertainty_score":0.02046794,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4377826847","doi":"10.1016/j.clml.2023.05.008","title":"Recommendations for Management of Secondary Antibody Deficiency in Multiple Myeloma","year":2023,"lang":"en","type":"review","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University Health Centre","funders":"CSL Behring","keywords":"Hypogammaglobulinemia; Medicine; Intensive care medicine; Immunodeficiency; Primary immunodeficiency; Disease; Antibody; Immunology; Pediatrics; Internal medicine; Immune system","authors":[{"name":"Sergio Giralt","is_ca":false},{"name":"Stephen Jolles","is_ca":false},{"name":"Tessa Kerre","is_ca":false},{"name":"Hillard M. Lazarus","is_ca":false},{"name":"S. Shahzad Mustafa","is_ca":false},{"name":"Genovefa A. Papanicolaou","is_ca":false},{"name":"Roberto Ria","is_ca":false},{"name":"Donald C. Vinh","is_ca":true},{"name":"John R. Wingard","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1972499887686222,"gpt":0.4681203793617792,"spread":0.2708703905931571,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004644656,0.000780024,0.001026955,0.001898315,0.001074731,0.001596642,0.002396594,0.004396753,0.01656308],"category_scores_gemma":[0.02166482,0.0003215352,0.002652189,0.001287997,0.0005419928,0.002138543,0.001628942,0.00565478,0.008476022],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001859022,"about_ca_system_score_gemma":0.005622769,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006574765,"about_ca_topic_score_gemma":0.01008497,"domain_scores_codex":[0.9956528,0.001963912,0.001011949,0.0002106948,0.0008935835,0.0002669385],"domain_scores_gemma":[0.9915375,0.002398029,0.0008365673,0.000228821,0.004098088,0.0009009432],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001244299,0.000216642,0.002698588,0.004581594,0.0001083118,0.0009524743,0.0005548652,0.0004413337,0.0004998267,0.003515691,0.6329298,0.3533764],"study_design_scores_gemma":[0.0001707418,0.00009271359,0.003097485,0.01555649,0.0002694996,0.001519622,0.0005317469,0.0003487854,0.0003338952,0.004839931,0.9731837,0.00005528642],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"review","genre_scores_codex":[0.005784031,0.2631222,0.02839776,0.5233554,0.02118331,0.00461597,0.005861219,0.002418633,0.1452615],"genre_scores_gemma":[0.06395487,0.3379376,0.2171299,0.2814337,0.01311615,0.007855433,0.01446899,0.0005919515,0.06351136],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.01656308,"threshold_uncertainty_score":0.05540907,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3161580798","doi":"10.1016/j.clml.2021.05.002","title":"Trajectory of Symptoms in Patients Undergoing Autologous Stem Cell Transplant for Multiple Myeloma: A Population-Based Cohort Study of Patient-Reported Outcomes","year":2021,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Hamilton Health Sciences; Institute of Aging; Juravinski Cancer Centre","funders":"Takeda Canada; Ontario Ministry of Health and Long-Term Care; Institute for Clinical Evaluative Sciences; Janssen Pharmaceuticals; Celgene; Sanofi; Roche; Amgen","keywords":"Medicine; Multiple myeloma; Population; Cohort; Internal medicine; Odds ratio; Environmental health","authors":[{"name":"Mohammed Ebraheem","is_ca":true},{"name":"Hsien Seow","is_ca":true},{"name":"Amaris Balitsky","is_ca":true},{"name":"Gregory R. Pond","is_ca":true},{"name":"Tanya M. Wildes","is_ca":true},{"name":"Branavan Sivapathasundaram","is_ca":true},{"name":"Jonathan Sussman","is_ca":true},{"name":"Hira Mian","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02771372705732486,"gpt":0.3153239903634349,"spread":0.2876102633061101,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006432419,0.0003412623,0.0004593827,0.0007681147,0.0007156914,0.001227458,0.0005961595,0.0008082299,0.001328381],"category_scores_gemma":[0.002467692,0.0003697482,0.0009730037,0.001371676,0.0003775535,0.001197477,0.001003679,0.00138053,0.000250935],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005269578,"about_ca_system_score_gemma":0.0005954652,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01030525,"about_ca_topic_score_gemma":0.01176163,"domain_scores_codex":[0.9993267,0.0001503504,0.00006828646,0.0001911692,0.00007903009,0.0001846112],"domain_scores_gemma":[0.9985649,0.0001462144,0.0006945739,0.0001156591,0.0001307597,0.0003479521],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00007280232,0.00003829219,0.9992705,0.000003000226,0.00006581208,0.0000454941,0.00007005726,0.00002624588,0.00007915364,0.00001413664,0.0000548288,0.0002597544],"study_design_scores_gemma":[0.000003931239,0.00006867907,0.9992472,0.000002998285,0.00002016934,0.0001308931,0.0003136488,0.0001132113,0.00001374361,0.00002163731,0.00005846945,0.000005383954],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.998996,0.0001473246,0.00005821264,0.00006364578,0.000007464311,0.000006299058,0.0004993407,0.000002987717,0.000218698],"genre_scores_gemma":[0.9993237,0.00007055172,0.00002920443,0.00002344572,0.000005409649,0.00000495212,0.0004511185,0.000001636647,0.00009011482],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01030525,"threshold_uncertainty_score":0.02049053,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2055127103","doi":"10.3816/clml.2010.n.015","title":"Bortezomib as a Treatment Option in Patients With Waldenström Macroglobulinemia","year":2010,"lang":"en","type":"review","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Bortezomib; Medicine; Rituximab; Waldenstrom macroglobulinemia; Macroglobulinemia; Internal medicine; Oncology; Proteasome inhibitor; Multiple myeloma; Lymphoma","authors":[{"name":"Meletios Α. Dimopoulos","is_ca":false},{"name":"Christine Chen","is_ca":true},{"name":"Efstathios Kastritis","is_ca":false},{"name":"Maria Gavriatopoulou","is_ca":false},{"name":"Steven P. Treon","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0433455937624061,"gpt":0.3944574783435849,"spread":0.3511118845811788,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000497237,0.0006680214,0.002095279,0.001767108,0.0002047176,0.000666132,0.0006564197,0.000726076,0.003181553],"category_scores_gemma":[0.000835565,0.000240219,0.000621497,0.001628323,0.0003169372,0.0007147541,0.0003614637,0.001276524,0.0008511369],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004589474,"about_ca_system_score_gemma":0.0008601238,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009260036,"about_ca_topic_score_gemma":0.003115145,"domain_scores_codex":[0.9998273,0.00003867694,0.00003864895,0.00003029246,0.00005075582,0.00001437964],"domain_scores_gemma":[0.9996668,0.0001798295,0.00007964749,0.000006520479,0.00004300788,0.0000242133],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003455349,0.00006336783,0.000447825,0.01774875,0.0003075356,0.0003767743,0.00003201754,0.000183547,0.001039908,0.0006437748,0.02588171,0.9529292],"study_design_scores_gemma":[0.0007519271,0.0006265946,0.005627876,0.01408937,0.002772131,0.007753499,0.0001363866,0.0002656584,0.001036659,0.001266999,0.9656222,0.00005070745],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001668446,0.9990528,0.0000414919,0.0001457069,0.0000914102,0.000003542047,0.00001360699,0.000003487216,0.0004810729],"genre_scores_gemma":[0.00224519,0.996664,0.0001678026,0.0003469587,0.0001937809,0.000009231475,0.00004846431,0.00000137945,0.0003231896],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003181553,"threshold_uncertainty_score":0.01064336,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2019329008","doi":"10.1016/j.clml.2014.04.004","title":"Clinical Features of Patients With Philadelphia-Negative Myeloproliferative Neoplasms Complicated by Portal Hypertension","year":2014,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Institute on Aging","keywords":"Medicine; Portal hypertension; Internal medicine; Ascites; Thrombosis; Myeloproliferative neoplasm; Gastroenterology; Polycythemia vera; Incidence (geometry); Population; Cardiology; Myelofibrosis; Cirrhosis; Bone marrow","authors":[{"name":"Matthew Yan","is_ca":true},{"name":"Holly L. Geyer","is_ca":false},{"name":"Ruben A. Mesa","is_ca":false},{"name":"Ehab Atallah","is_ca":false},{"name":"Jeannie Callum","is_ca":true},{"name":"Justyna Bartoszko","is_ca":true},{"name":"Karen Yee","is_ca":true},{"name":"Manjula Maganti","is_ca":true},{"name":"Florence Wong","is_ca":true},{"name":"Vikas Gupta","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01999936816398753,"gpt":0.2955877178174157,"spread":0.2755883496534282,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002121736,0.0004031907,0.0005163892,0.001056984,0.0005954402,0.0005551391,0.0002309115,0.0005376168,0.002454443],"category_scores_gemma":[0.00204628,0.0001938406,0.0002983527,0.001050066,0.0003926464,0.0006654105,0.0004804234,0.0004487547,0.0003234738],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002144434,"about_ca_system_score_gemma":0.0003307721,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008111688,"about_ca_topic_score_gemma":0.0007013358,"domain_scores_codex":[0.9997101,0.00005274174,0.00004489197,0.00004785978,0.00004947281,0.0000948043],"domain_scores_gemma":[0.9988071,0.0003112486,0.0003248134,0.00003618826,0.00007898003,0.0004417441],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004917026,0.00007182688,0.9778793,0.00001728635,0.00002147874,0.01761056,0.0001009583,0.00007249994,0.001165579,0.00007156418,0.000223115,0.002274086],"study_design_scores_gemma":[0.00004165151,0.0003066886,0.9257588,0.00001380517,0.00003004862,0.07226306,0.0004256598,0.0002523652,0.0002155198,0.0001165605,0.000560142,0.00001557065],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9954315,0.0006279211,0.0001102229,0.0001345598,0.00001584547,0.00001953127,0.0001996537,0.000008789163,0.003451935],"genre_scores_gemma":[0.9992228,0.0002016192,0.00006274995,0.00005740127,0.00004530126,0.000008846338,0.0002459319,0.000001894732,0.0001534896],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002454443,"threshold_uncertainty_score":0.008210897,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2411574854","doi":"10.1016/j.clml.2016.06.006","title":"Vaccination in Multiple Myeloma: Review of Current Literature","year":2016,"lang":"en","type":"review","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Aurora Research Institute","keywords":"Multiple myeloma; Vaccination; Medicine; Current (fluid); Virology; Immunology; Engineering","authors":[{"name":"Andinet Alemu","is_ca":false},{"name":"John O. Richards","is_ca":false},{"name":"Martin K. Oaks","is_ca":false},{"name":"Michael A. Thompson","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1076897470261745,"gpt":0.445554923738294,"spread":0.3378651767121195,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001118118,0.0007996323,0.002543439,0.003376972,0.0002703562,0.001198905,0.0009792855,0.00136569,0.003274288],"category_scores_gemma":[0.00274334,0.0004250017,0.001299455,0.003584546,0.0003989786,0.001467292,0.0007959025,0.00112122,0.0004529361],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005363117,"about_ca_system_score_gemma":0.00188793,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001994763,"about_ca_topic_score_gemma":0.004164126,"domain_scores_codex":[0.9995044,0.0001064421,0.0001763371,0.00007618926,0.0001071237,0.00002948814],"domain_scores_gemma":[0.9984297,0.001032617,0.0003279443,0.00001859361,0.0001454514,0.00004570817],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002900368,0.0001040576,0.0009554906,0.2685939,0.0009333825,0.000320232,0.0001582624,0.0003138348,0.0008180991,0.0008778911,0.01931419,0.7073206],"study_design_scores_gemma":[0.0002266424,0.0005420616,0.007692811,0.2183723,0.008420601,0.004032646,0.0005260798,0.0002888387,0.0006370847,0.001959285,0.7572011,0.0001005119],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00006432311,0.9996833,0.00001673486,0.00007921662,0.00004541062,0.000003299736,0.0000152755,0.00000115211,0.00009130361],"genre_scores_gemma":[0.0004962251,0.999185,0.00007212057,0.000125467,0.00006939789,0.000004050575,0.00001399885,3.131013e-7,0.00003337689],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003376972,"threshold_uncertainty_score":0.01095361,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2147495729","doi":"10.1016/j.clml.2013.07.003","title":"Multiple Myeloma International Staging System: “Staging” or Simply “Aging” System?","year":2013,"lang":"en","type":"review","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"Cedars-Sinai Medical Center","keywords":"Staging system; Medicine; Multiple myeloma; Comorbidity; Malignancy; Hematologic malignancy; Oncology; Internal medicine; TNM staging system; Cancer","authors":[{"name":"Régis Bataille","is_ca":false},{"name":"Cédric Annweiler","is_ca":true},{"name":"Olivier Beauchet","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1129323935066195,"gpt":0.4167401753694728,"spread":0.3038077818628534,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002438992,0.0009912414,0.002188893,0.003200887,0.0003698007,0.001351954,0.001636086,0.00131733,0.003262025],"category_scores_gemma":[0.003528022,0.0003128612,0.0008328552,0.004549454,0.001140352,0.002172971,0.001247283,0.002353892,0.001540928],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00200181,"about_ca_system_score_gemma":0.005329675,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00603468,"about_ca_topic_score_gemma":0.008788804,"domain_scores_codex":[0.9992954,0.0001911787,0.0001563476,0.0000878482,0.0001977618,0.00007152934],"domain_scores_gemma":[0.9986233,0.0003383894,0.0002546583,0.00003337429,0.0006106537,0.0001396776],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007739456,0.00002279938,0.0008843445,0.007935015,0.0001200507,0.00006652868,0.00004997974,0.0001796341,0.0001797314,0.003912413,0.2953291,0.6912429],"study_design_scores_gemma":[0.00003846601,0.00004526352,0.001787405,0.005794184,0.000219469,0.0004437531,0.0001125262,0.0000928795,0.00007628388,0.002184592,0.9891802,0.00002500471],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001294599,0.9894477,0.0001957978,0.006019335,0.003095464,0.000009529805,0.000101162,0.00001656642,0.0009849642],"genre_scores_gemma":[0.001726234,0.9886641,0.0007371646,0.004927839,0.002385378,0.0000251708,0.0003083636,0.00000652283,0.001219242],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00603468,"threshold_uncertainty_score":0.01452422,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2781661609","doi":"10.1016/j.clml.2017.12.011","title":"A Comparison of the Efficacy of Immunomodulatory-containing Regimens in Relapsed/Refractory Multiple Myeloma: A Network Meta-analysis","year":2018,"lang":"en","type":"review","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"Janssen Pharmaceuticals","keywords":"Lenalidomide; Medicine; Internal medicine; Daratumumab; Oncology; Carfilzomib; Ixazomib; Multiple myeloma; Hazard ratio; Subgroup analysis; Pomalidomide; Progression-free survival; Meta-analysis; Chemotherapy; Confidence interval","authors":[{"name":"Meletios Α. Dimopoulos","is_ca":false},{"name":"Jonathan L. Kaufman","is_ca":false},{"name":"Darrell White","is_ca":true},{"name":"Gordon Cook","is_ca":false},{"name":"Maria Teresa Rizzo","is_ca":false},{"name":"Yingxin Xu","is_ca":false},{"name":"Kyle Fahrbach","is_ca":false},{"name":"Maren Gaudig","is_ca":false},{"name":"Mary Slavcev","is_ca":false},{"name":"Lindsay Dearden","is_ca":false},{"name":"Annette Lam","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2118797590462149,"gpt":0.4481643213528339,"spread":0.236284562306619,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007858591,0.002312141,0.01185361,0.002095696,0.0003734247,0.00211923,0.001889026,0.001680478,0.003445475],"category_scores_gemma":[0.01491757,0.001045415,0.03183194,0.003336785,0.0004454113,0.001353611,0.001200986,0.002326074,0.0002536035],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001435153,"about_ca_system_score_gemma":0.001177442,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005653364,"about_ca_topic_score_gemma":0.00930857,"domain_scores_codex":[0.9945,0.003027365,0.0009731698,0.0008639478,0.0004188067,0.0002166186],"domain_scores_gemma":[0.9918764,0.00638047,0.0009036438,0.0003545953,0.0003419231,0.0001430333],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.01047639,0.00004060068,0.006750115,0.04972444,0.9202395,0.00007010325,0.00004220957,0.0009143546,0.0002543068,0.0001344023,0.0004753601,0.01087814],"study_design_scores_gemma":[0.001392262,0.0002680919,0.004910421,0.001917334,0.989987,0.00004310878,0.0000236002,0.0002878163,0.00006620923,0.0002075957,0.000879882,0.00001676746],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.02400876,0.9732608,0.0009732862,0.0002138783,0.0002214378,0.0000935103,0.0008390179,0.00002863696,0.0003607257],"genre_scores_gemma":[0.5751657,0.4172688,0.003084825,0.001202208,0.0004424458,0.0003103792,0.001936854,0.00006509529,0.00052361],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01185361,"threshold_uncertainty_score":0.04156071,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4323353350","doi":"10.1016/j.clml.2023.03.002","title":"Response to COVID-19 Vaccination Post-CAR T Therapy in Patients With Non-Hodgkin Lymphoma and Multiple Myeloma","year":2023,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Loxo Oncology; Pharmacyclics; Kite Pharma; Genentech; National Cancer Institute; Gilead Sciences; Servier; Alexion Pharmaceuticals; Apellis Pharmaceuticals; BeiGene; Pfizer; Incyte; Innovent Biologics; Adaptive Biotechnologies; Sierra Oncology; CTI Biopharma; bluebird bio; TG Therapeutics; Regeneron Pharmaceuticals; Sanofi; Amgen; AstraZeneca; Cidara Therapeutics; MorphoSys; Celgene; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Vaccination; Seroconversion; Lymphoma; Immunology; Multiple myeloma; Antibody; Cancer; Chimeric antigen receptor; Immune system; Immunotherapy; Virology; Internal medicine","authors":[{"name":"Julia E. Wiedmeier","is_ca":false},{"name":"Madiha Iqbal","is_ca":false},{"name":"Allison Rosenthal","is_ca":false},{"name":"Evandro D. Bezerra","is_ca":false},{"name":"Juan Esteban García-Robledo","is_ca":false},{"name":"Radhika Bansal","is_ca":false},{"name":"Patrick B. Johnston","is_ca":false},{"name":"Matthew Hathcock","is_ca":false},{"name":"Jeremy T. Larsen","is_ca":false},{"name":"P. Leif Bergsagel","is_ca":false},{"name":"Yucai Wang","is_ca":false},{"name":"Craig B. Reeder","is_ca":false},{"name":"José F. Leis","is_ca":false},{"name":"Rafaël Fonseca","is_ca":false},{"name":"Jeanne Palmer","is_ca":false},{"name":"Brianna J. Negaard","is_ca":false},{"name":"Raphael Mwangi","is_ca":false},{"name":"Rahma Warsame","is_ca":false},{"name":"Taxiarchis Kourelis","is_ca":false},{"name":"Suzanne R. Hayman","is_ca":false},{"name":"David Dingli","is_ca":false},{"name":"Prashant Kapoor","is_ca":false},{"name":"Shaji Kumar","is_ca":false},{"name":"Urshila Durani","is_ca":false},{"name":"José C. Villasboas","is_ca":false},{"name":"Jonas Paludo","is_ca":false},{"name":"N. Nora Bennani","is_ca":false},{"name":"Grzegorz S. Nowakowski","is_ca":false},{"name":"Stephen M. Ansell","is_ca":false},{"name":"Januario E. Castro","is_ca":false},{"name":"Mohamed A. Kharfan‐Dabaja","is_ca":false},{"name":"Yi Lin","is_ca":false},{"name":"Paschalis Vergidis","is_ca":false},{"name":"Hemant S. Murthy","is_ca":false},{"name":"Javier Muñoz","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03695353903935361,"gpt":0.3572703254441805,"spread":0.3203167864048269,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004631198,0.0002567216,0.0005588031,0.0003242744,0.0003625911,0.0005259367,0.0002490107,0.0007043667,0.001824833],"category_scores_gemma":[0.002279836,0.0001611158,0.0004830548,0.0003707453,0.000239872,0.0004810429,0.000288063,0.0007767992,0.0003105797],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005482665,"about_ca_system_score_gemma":0.0002974342,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001743339,"about_ca_topic_score_gemma":0.002342059,"domain_scores_codex":[0.9995193,0.0001301398,0.00003625059,0.0000869949,0.00005682014,0.0001704634],"domain_scores_gemma":[0.9990257,0.000392033,0.0002034819,0.00003402678,0.00008143286,0.0002632165],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.009157254,0.0004995675,0.972177,0.00005533837,0.0001611748,0.0007184517,0.000216316,0.0002693041,0.00217108,0.00003374332,0.0006043396,0.01393635],"study_design_scores_gemma":[0.0001873825,0.003688346,0.993258,0.00001707715,0.0001217001,0.0007786778,0.0002814065,0.000479282,0.0003316197,0.00004323768,0.0008021612,0.0000110004],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9979239,0.0005518837,0.00003438742,0.000153095,0.00002862389,0.00001515354,0.000143998,0.000005692006,0.001143228],"genre_scores_gemma":[0.9992918,0.00007553738,0.00001912046,0.0001329967,0.00003043691,0.00001064138,0.0001851945,0.000001174525,0.0002530136],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001824833,"threshold_uncertainty_score":0.006104648,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2980239934","doi":"10.1016/j.clml.2019.09.618","title":"Adherence to Lenalidomide in Older Adults With Newly Diagnosed Multiple Myeloma","year":2019,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Juravinski Cancer Centre; McMaster University","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; National Institutes of Health; Agency for Healthcare Research and Quality; National Cancer Institute; Institute of Translational Health Sciences, University of Washington; Centers for Medicare and Medicaid Services","keywords":"Lenalidomide; Multiple myeloma; Medicine; Internal medicine; Oncology","authors":[{"name":"Hira Mian","is_ca":true},{"name":"Mark A. Fiala","is_ca":false},{"name":"Tanya M. Wildes","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02879022313772613,"gpt":0.3314337427988169,"spread":0.3026435196610908,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005514638,0.0001342221,0.0004639394,0.0005005422,0.0004933249,0.0006989624,0.0002265614,0.0005531426,0.001765882],"category_scores_gemma":[0.004947857,0.0001340886,0.0006430862,0.0009643,0.0001473377,0.0005728618,0.0004059575,0.0008983916,0.00009818091],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005434145,"about_ca_system_score_gemma":0.0004489768,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01260614,"about_ca_topic_score_gemma":0.02376324,"domain_scores_codex":[0.9992623,0.000152937,0.000164763,0.00009609424,0.0001900535,0.0001339404],"domain_scores_gemma":[0.9979063,0.0004071517,0.001170183,0.00006619236,0.0001888395,0.0002613837],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001805454,0.000134499,0.9892969,0.00005391099,0.0002166009,0.00008618666,0.0001889591,0.00004030898,0.0000551195,0.00004256117,0.0003948209,0.009309704],"study_design_scores_gemma":[0.00002188519,0.000126594,0.9977199,0.00006823573,0.0001463144,0.0002450182,0.0005922698,0.0001619088,0.00002575112,0.00006883442,0.0008168325,0.00000630104],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9880706,0.005458561,0.00008572511,0.0009884875,0.00009300662,0.00002310259,0.0005139682,0.000004411436,0.004762139],"genre_scores_gemma":[0.9972456,0.001291237,0.00007548465,0.0005269921,0.00007511969,0.00001141211,0.0002887079,0.000001137204,0.0004843126],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01260614,"threshold_uncertainty_score":0.02506554,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3188942243","doi":"10.1016/j.clml.2021.07.028","title":"Management of Myeloma Manifestations and Complications: The Cornerstone of Supportive Care: Recommendation of the Canadian Myeloma Research Group (formerly Myeloma Canada Research Network) Consensus Guideline Consortium","year":2021,"lang":"en","type":"review","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"University of British Columbia; London Health Sciences Centre; Vancouver General Hospital; CancerCare Manitoba; Memorial University of Newfoundland; University of Manitoba; Centre hospitalier universitaire de Québec; Université de Montréal; Western University; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Guideline; Multiple myeloma; Medicine; Family medicine; Intensive care medicine; Disease; Internal medicine; Pathology","authors":[{"name":"Richard LeBlanc","is_ca":true},{"name":"Debra Bergstrom","is_ca":true},{"name":"Julie Anne Côté","is_ca":true},{"name":"Rami Kotb","is_ca":true},{"name":"Martha Louzada","is_ca":true},{"name":"Heather J. Sutherland","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1755803312582497,"gpt":0.460361134728241,"spread":0.2847808034699913,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005761123,0.001337206,0.005294143,0.004001956,0.001097116,0.002171526,0.004704747,0.004009033,0.00289065],"category_scores_gemma":[0.01001,0.0006996808,0.006123484,0.003873549,0.000697662,0.001537225,0.001450242,0.006122155,0.001586419],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005960809,"about_ca_system_score_gemma":0.02507615,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.06432509,"about_ca_topic_score_gemma":0.1403583,"domain_scores_codex":[0.9965503,0.000850681,0.001084274,0.0002096581,0.001072982,0.0002321175],"domain_scores_gemma":[0.9938413,0.001590132,0.001156531,0.00008329868,0.002932525,0.0003961838],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004191828,0.0001988805,0.002268707,0.08333834,0.002265562,0.0003167884,0.0002323382,0.001039829,0.0008237281,0.004432163,0.3858394,0.5188252],"study_design_scores_gemma":[0.001480856,0.0001994945,0.01057198,0.2490709,0.007639397,0.0009566789,0.0003099273,0.000771562,0.0006194409,0.003927419,0.7243136,0.0001386832],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0008122121,0.925624,0.002872096,0.05306762,0.003899228,0.001273364,0.00315077,0.000125805,0.009174868],"genre_scores_gemma":[0.00786229,0.9220484,0.02160285,0.03695337,0.001741079,0.001430192,0.004988232,0.00003965098,0.003333821],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9940392,"threshold_uncertainty_score":0.1279014,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1963599260","doi":"10.1016/j.clml.2013.05.012","title":"A Critical Review of Trials of First-Line BCR-ABL Inhibitor Treatment in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase","year":2013,"lang":"en","type":"review","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Nilotinib; Dasatinib; Imatinib; Medicine; Tyrosine-kinase inhibitor; Myeloid leukemia; Tyrosine kinase; Internal medicine; Clinical trial; Oncology; Pharmacology; Cancer","authors":[{"name":"Elias Jabbour","is_ca":false},{"name":"Jeffrey H. Lipton","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08339020883833671,"gpt":0.4046808406504899,"spread":0.3212906318121532,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002581247,0.0008926913,0.004221435,0.002122336,0.000267619,0.00120112,0.00164365,0.001078602,0.00378601],"category_scores_gemma":[0.005790762,0.0004404104,0.002881592,0.002523683,0.0003989409,0.001083443,0.000587443,0.001313342,0.0004050979],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001256473,"about_ca_system_score_gemma":0.002998557,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002287054,"about_ca_topic_score_gemma":0.007208119,"domain_scores_codex":[0.9990495,0.0002632827,0.0003520744,0.000103428,0.000190622,0.00004111119],"domain_scores_gemma":[0.9969223,0.002071232,0.0005629717,0.00004204761,0.0003335144,0.00006794069],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.001036968,0.00006506103,0.0002946096,0.4838243,0.003493035,0.0001306851,0.00009754483,0.0002748115,0.0007526199,0.0008700106,0.02000813,0.4891523],"study_design_scores_gemma":[0.001780756,0.001377911,0.00460354,0.4038271,0.04673885,0.001378239,0.0002240177,0.0002200225,0.0007874158,0.001476928,0.5374982,0.0000871481],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000125106,0.9993048,0.00004556066,0.0001542385,0.00009702186,0.00002508752,0.00005333784,0.000002954579,0.0001918596],"genre_scores_gemma":[0.001320365,0.9977265,0.0002170888,0.0005001522,0.00006439017,0.00003076337,0.00005724288,0.000001477155,0.00008187451],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004221435,"threshold_uncertainty_score":0.01365113,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1986307017","doi":"10.1016/j.clml.2012.01.003","title":"Detection of CD34, TdT, CD56, CD2, CD4, and CD14 by Flow Cytometry Is Associated With NPM1 and FLT3 Mutation Status in Cytogenetically Normal Acute Myeloid Leukemia","year":2012,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Occupational Cancer Research Centre; Vancouver General Hospital","funders":"BC Cancer Agency; University of British Columbia","keywords":"NPM1; CD34; Flow cytometry; CD19; Myeloid leukemia; CD33; CD14; Mutation; Gene mutation; Leukemia; Medicine; Molecular biology; Cancer research; Myeloid; Internal medicine; Immunology; Oncology; Biology; Gene; Karyotype; Genetics; Stem cell","authors":[{"name":"Bakul I. Dalal","is_ca":true},{"name":"Soudeh Mansoor","is_ca":true},{"name":"Mita Manna","is_ca":true},{"name":"Steven Pi","is_ca":true},{"name":"Giovanna Di Sauro","is_ca":true},{"name":"Donna E. Hogge","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01838067840154703,"gpt":0.3085404674738134,"spread":0.2901597890722664,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005261081,0.0002394813,0.0002364478,0.001656368,0.0003158221,0.0006131466,0.0004251109,0.0006863509,0.001390293],"category_scores_gemma":[0.00233787,0.0002594425,0.0001011248,0.0006028004,0.0005472479,0.0004233983,0.0002736147,0.0004630159,0.0002989068],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003688963,"about_ca_system_score_gemma":0.0001865839,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008128792,"about_ca_topic_score_gemma":0.0009053517,"domain_scores_codex":[0.9995627,0.00009905351,0.00006202963,0.00006635086,0.0001060991,0.000103808],"domain_scores_gemma":[0.9988714,0.0005509543,0.0002507285,0.00006102251,0.0001128604,0.0001530057],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003003818,0.0002653345,0.6699636,0.00004304819,0.00004795457,0.001784237,0.0002749738,0.0004666758,0.3106875,0.0004023992,0.0003253194,0.01273518],"study_design_scores_gemma":[0.0000644661,0.0004968164,0.9213831,0.00001860724,0.00007508355,0.009747725,0.0002997576,0.005506136,0.06054094,0.0006678589,0.001180982,0.00001856654],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9990488,0.0001984533,0.0002243469,0.00003423269,0.000003340072,0.00000476698,0.00003365086,0.000009105359,0.0004434412],"genre_scores_gemma":[0.9992657,0.00006803068,0.0003191507,0.00002445942,0.000008067683,0.000009162384,0.00009545949,0.000002835407,0.0002070844],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001656368,"threshold_uncertainty_score":0.00465095,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1973979329","doi":"10.1016/j.clml.2014.07.015","title":"A Canadian Evidence-Based Guideline for the First-Line Treatment of Follicular Lymphoma: Joint Consensus of the Lymphoma Canada Scientific Advisory Board","year":2014,"lang":"en","type":"review","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"University of British Columbia; Queen Elizabeth II Health Sciences Centre; University of Calgary; McGill University; University of Toronto; Dalhousie University; BC Cancer Agency; Princess Margaret Cancer Centre; Jewish General Hospital","funders":"","keywords":"Guideline; Follicular lymphoma; Medicine; Lymphoma; Family medicine; Disease; Executive summary; Intensive care medicine; Front line; Internal medicine; Political science; Pathology","authors":[{"name":"John Kuruvilla","is_ca":true},{"name":"Sarit Assouline","is_ca":true},{"name":"David Hodgson","is_ca":true},{"name":"David MacDonald","is_ca":true},{"name":"Doug Stewart","is_ca":true},{"name":"Anna Christofides","is_ca":false},{"name":"Marina Komolova","is_ca":false},{"name":"Joseph Connors","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1035812907999964,"gpt":0.3549666461944209,"spread":0.2513853553944245,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01144169,0.001818366,0.006509836,0.008755339,0.001663361,0.003264289,0.007004296,0.0051287,0.004728932],"category_scores_gemma":[0.02081024,0.0009917198,0.007303058,0.009752499,0.001175044,0.001966162,0.001762745,0.006023553,0.001573639],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01871968,"about_ca_system_score_gemma":0.08626755,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.3002461,"about_ca_topic_score_gemma":0.4894407,"domain_scores_codex":[0.9928463,0.001522511,0.001995948,0.0004079117,0.002834523,0.0003928547],"domain_scores_gemma":[0.9852925,0.003426802,0.001880113,0.0001705956,0.008518959,0.000711019],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0005291512,0.0001387687,0.001114868,0.183805,0.003041366,0.0003562006,0.0002839978,0.0008624742,0.0007692734,0.003721476,0.4104191,0.3949583],"study_design_scores_gemma":[0.001112475,0.000101735,0.006330519,0.2915788,0.01355176,0.0005858842,0.0002063014,0.0004553052,0.0004463557,0.002146685,0.6833178,0.0001663912],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002998813,0.9716002,0.001325132,0.01565561,0.003085075,0.0009257881,0.002432025,0.00006101959,0.004615217],"genre_scores_gemma":[0.004002012,0.9672738,0.01135619,0.01025319,0.0006834267,0.0007495294,0.003303046,0.00002861806,0.002350181],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6997539,"threshold_uncertainty_score":0.596997,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2943115873","doi":"10.1016/j.clml.2019.04.014","title":"Geriatric Assessment and Frailty Scores Predict Mortality in Myeloma: Systematic Review and Meta-analysis","year":2019,"lang":"en","type":"review","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"American Society of Clinical Oncology; Janssen Biotech; National Cancer Institute; Foundation for the National Institutes of Health","keywords":"Medicine; Meta-analysis; Hazard ratio; Multiple myeloma; Internal medicine; Confidence interval; Incidence (geometry); Adverse effect","authors":[{"name":"Ana S. Salazar","is_ca":false},{"name":"Luisa Recinos","is_ca":false},{"name":"Hira Mian","is_ca":true},{"name":"C Stoll","is_ca":false},{"name":"Laura Simon","is_ca":false},{"name":"Subhjit Sekhon","is_ca":false},{"name":"Graham A. Colditz","is_ca":false},{"name":"Tanya M. Wildes","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2212138162500832,"gpt":0.4785600637822102,"spread":0.257346247532127,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004880197,0.002431138,0.01334813,0.003086555,0.000538298,0.002289182,0.002048231,0.002286744,0.004660792],"category_scores_gemma":[0.01437549,0.001521796,0.02984189,0.004880269,0.0006250357,0.001581503,0.001911417,0.002265901,0.0004391186],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001466306,"about_ca_system_score_gemma":0.002719666,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01106313,"about_ca_topic_score_gemma":0.03260262,"domain_scores_codex":[0.9973552,0.0009629249,0.0007819756,0.0004520118,0.000282621,0.0001652743],"domain_scores_gemma":[0.9931256,0.004892873,0.001138983,0.0002641811,0.0004371571,0.0001411696],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.002122751,0.00004879843,0.009158576,0.3045592,0.6666802,0.0001182647,0.0001041284,0.0004368352,0.0001937826,0.0001101234,0.001142775,0.01532452],"study_design_scores_gemma":[0.0006064076,0.0001255771,0.006475625,0.01244522,0.9786448,0.00006874143,0.0000471175,0.0001274406,0.00004177717,0.0001496122,0.001237778,0.00002977243],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.005432589,0.9934291,0.000249514,0.0001290703,0.0001034186,0.00007866783,0.0004250273,0.00001782115,0.0001347972],"genre_scores_gemma":[0.1678658,0.8277338,0.001433275,0.001052473,0.0002875533,0.0003465865,0.0008339878,0.00002436935,0.0004222287],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01334813,"threshold_uncertainty_score":0.02580929,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4226022053","doi":"10.1016/j.clml.2021.12.003","title":"An Overview of CAR T Cell Mediated B Cell Maturation Antigen Therapy","year":2021,"lang":"en","type":"review","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Emergent BioSolutions (Canada)","funders":"","keywords":"Chimeric antigen receptor; Multiple myeloma; Medicine; Malignancy; Plasma cell; Antigen; Cancer research; Antibody; Clinical trial; Cancer; Immunology; Oncology; Immunotherapy; Internal medicine","authors":[{"name":"Sameer Quazi","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1708511973895735,"gpt":0.4525105370994986,"spread":0.2816593397099251,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008530461,0.001088317,0.00188495,0.002411729,0.0002638164,0.001282655,0.001145397,0.001300656,0.004586591],"category_scores_gemma":[0.0007389914,0.0004026779,0.0008223084,0.002194979,0.0004500429,0.001313073,0.000718245,0.002637008,0.002378976],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008917515,"about_ca_system_score_gemma":0.001308043,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001285081,"about_ca_topic_score_gemma":0.002620984,"domain_scores_codex":[0.9997926,0.000043003,0.00002676766,0.00004003606,0.00006491296,0.00003262006],"domain_scores_gemma":[0.9996945,0.0001651846,0.00003747588,0.000008053398,0.00006412606,0.00003073752],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001720375,0.0001663079,0.000114976,0.01939608,0.0001238917,0.0001558966,0.00003177549,0.0005563181,0.002174562,0.003822144,0.04477119,0.9285147],"study_design_scores_gemma":[0.00009177069,0.0003442136,0.0004184077,0.003610188,0.0002179021,0.000732441,0.00002588018,0.0001819833,0.0006496839,0.001159237,0.9925487,0.00001958425],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00007941661,0.9985663,0.0001698764,0.0002084611,0.0001896327,0.000008834171,0.00002431208,0.000009258468,0.0007438842],"genre_scores_gemma":[0.0005529131,0.9980433,0.0002696202,0.0003189772,0.0001873833,0.00001314996,0.00005101824,0.000002029068,0.0005615024],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004586591,"threshold_uncertainty_score":0.01534361,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2776794568","doi":"10.1016/j.clml.2017.12.004","title":"The Effect of Lenalidomide on Health-Related Quality of Life in Patients With Lower-Risk Non-del(5q) Myelodysplastic Syndromes: Results From the MDS-005 Study","year":2017,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Lenalidomide; Medicine; Placebo; Myelodysplastic syndromes; Discontinuation; Quality of life (healthcare); Internal medicine; International Prognostic Scoring System; Anemia; Randomized controlled trial; Physical therapy; Multiple myeloma; Bone marrow","authors":[{"name":"Valeria Santini","is_ca":false},{"name":"António Almeida","is_ca":false},{"name":"Aristoteles Giagounidis","is_ca":false},{"name":"Uwe Platzbecker","is_ca":false},{"name":"Rena Buckstein","is_ca":true},{"name":"C. L. Beach","is_ca":false},{"name":"Shien Guo","is_ca":false},{"name":"Arman Altincatal","is_ca":false},{"name":"Chengqing Wu","is_ca":false},{"name":"Pierre Fenaux","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0369554667939113,"gpt":0.3581188018206333,"spread":0.321163335026722,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001805966,0.0006104777,0.0009238137,0.0002380984,0.0001654138,0.0006771343,0.0005052236,0.0005031353,0.001471517],"category_scores_gemma":[0.001069858,0.0001948665,0.001698716,0.0003032936,0.0003344469,0.0002714192,0.0002915565,0.0007449343,0.0001639327],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000632302,"about_ca_system_score_gemma":0.0004830115,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001174651,"about_ca_topic_score_gemma":0.002595455,"domain_scores_codex":[0.9993445,0.0003867978,0.00006452055,0.00006095554,0.00008772317,0.00005542153],"domain_scores_gemma":[0.9993418,0.0001432057,0.0002638109,0.00003752123,0.00003658346,0.000177108],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.654407,0.01208054,0.1860634,0.001968058,0.01441708,0.000184956,0.0002327132,0.001656406,0.009414751,0.000205106,0.002555902,0.1168141],"study_design_scores_gemma":[0.2182664,0.1573638,0.6071732,0.0003249288,0.008302508,0.0003597213,0.0001963043,0.001490792,0.002212536,0.0001837879,0.004070546,0.00005548227],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9910902,0.007209281,0.00008907743,0.0001549813,0.00002902785,0.0001559826,0.0005871356,0.000009850024,0.000674489],"genre_scores_gemma":[0.9972204,0.00122359,0.0001859694,0.0002329562,0.00004155375,0.0000910685,0.0007453337,0.000002091979,0.0002569786],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001805966,"threshold_uncertainty_score":0.009550929,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2055073381","doi":"10.1016/j.clml.2013.09.010","title":"A Comparison of Long-Term Outcomes of Donor Lymphocyte Infusions and Tyrosine Kinase Inhibitors in Patients With Relapsed CML After Allogeneic Hematopoietic Cell Transplantation","year":2013,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Hematopoietic cell; Tyrosine kinase; Medicine; Lymphocyte; Hematopoietic stem cell transplantation; Haematopoiesis; Immunology; Transplantation; Term (time); Oncology; Cancer research; Internal medicine; Stem cell; Biology; Receptor; Genetics","authors":[{"name":"Mohamed Shanavas","is_ca":true},{"name":"Hans A. Messner","is_ca":true},{"name":"Suzanne Kamel‐Reid","is_ca":true},{"name":"Eshetu G. Atenafu","is_ca":true},{"name":"Vikas Gupta","is_ca":true},{"name":"John Kuruvilla","is_ca":true},{"name":"Dennis Dong Hwan Kim","is_ca":true},{"name":"Jieun Uhm","is_ca":true},{"name":"Anna Lambie","is_ca":true},{"name":"Laura Ellis","is_ca":true},{"name":"Jeffrey H. Lipton","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0172757160603624,"gpt":0.2979828592730306,"spread":0.2807071432126683,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001167258,0.0002745942,0.0009258094,0.0003819266,0.0003158971,0.0008721203,0.0004178026,0.0006768178,0.00120489],"category_scores_gemma":[0.002325874,0.0001289047,0.00138568,0.0005943924,0.0003145561,0.0008725862,0.0005598998,0.0008652626,0.000182213],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000721973,"about_ca_system_score_gemma":0.0004752165,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009156321,"about_ca_topic_score_gemma":0.001590778,"domain_scores_codex":[0.9994172,0.0001901903,0.00007479893,0.00007942729,0.00007459085,0.0001637855],"domain_scores_gemma":[0.998273,0.0005635615,0.0005612441,0.00007211605,0.0001149433,0.0004151317],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1818512,0.001763047,0.7641125,0.0002969059,0.002493107,0.0005200646,0.000297625,0.001141617,0.002090791,0.0002379155,0.0005428694,0.04465236],"study_design_scores_gemma":[0.00443545,0.03558039,0.9540252,0.00008857349,0.001936657,0.0006199245,0.0006188157,0.0008275259,0.0005448313,0.0002840849,0.0009980411,0.00004044885],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9971657,0.002003626,0.00005016416,0.00007027186,0.00002712391,0.00001312628,0.0001739608,0.000001562285,0.0004945507],"genre_scores_gemma":[0.9986756,0.0004738956,0.00002608661,0.00008868073,0.00005552479,0.00001261256,0.0005214842,0.00000115879,0.0001450602],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00120489,"threshold_uncertainty_score":0.006173074,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4389623269","doi":"10.1016/j.clml.2023.12.005","title":"Mosunetuzumab Safety Profile in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma: Clinical Management Experience From a Pivotal Phase I/II Trial","year":2023,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Jewish General Hospital; Roche (Canada)","funders":"Genentech; F. Hoffmann-La Roche; Roche; Roche Canada","keywords":"Medicine; Internal medicine; Cytokine release syndrome; Follicular lymphoma; Neutropenia; Lymphoma; Adverse effect; Febrile neutropenia; Gastroenterology; Tumor lysis syndrome; Refractory (planetary science); Rituximab; Cyclophosphamide; Oncology; Surgery; Cancer; Chemotherapy; Immunotherapy","authors":[{"name":"Matthew J. Matasar","is_ca":false},{"name":"Nancy L. Bartlett","is_ca":false},{"name":"Mazyar Shadman","is_ca":false},{"name":"Lihua E. Budde","is_ca":false},{"name":"Ian W. Flinn","is_ca":false},{"name":"Gareth P. Gregory","is_ca":false},{"name":"Won Seog Kim","is_ca":false},{"name":"Georg Heß","is_ca":false},{"name":"Dima El‐Sharkawi","is_ca":false},{"name":"Catherine Diefenbach","is_ca":false},{"name":"Huang Huang","is_ca":true},{"name":"Iris To","is_ca":false},{"name":"Joana Parreira","is_ca":false},{"name":"Mei Wu","is_ca":false},{"name":"Antonia Kwan","is_ca":false},{"name":"Sarit Assouline","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03510957312794868,"gpt":0.3631146871045697,"spread":0.328005113976621,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001328695,0.0004358896,0.001051248,0.0001532074,0.0002337814,0.0008813101,0.0002915476,0.000382107,0.0009668012],"category_scores_gemma":[0.0008821082,0.0001475375,0.0006103762,0.0002342318,0.0003468217,0.0004632154,0.0001561029,0.001610098,0.000303891],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005410036,"about_ca_system_score_gemma":0.0004830928,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003654599,"about_ca_topic_score_gemma":0.00112445,"domain_scores_codex":[0.9997393,0.0001104206,0.00001533951,0.00003941048,0.0000369839,0.00005845798],"domain_scores_gemma":[0.9996283,0.00009847771,0.00009886211,0.00003134473,0.00002922849,0.0001137904],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3099853,0.01133758,0.04595874,0.001293807,0.003915302,0.0006426129,0.0007175545,0.005227983,0.1320331,0.0007618893,0.01168718,0.4764389],"study_design_scores_gemma":[0.2621295,0.4234248,0.241499,0.0003339835,0.005275256,0.003698347,0.0004025705,0.007318409,0.02139072,0.001270333,0.03313244,0.00012469],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9911759,0.006053114,0.0002954288,0.00039919,0.0000394744,0.0001391123,0.0004496313,0.0000320263,0.001416154],"genre_scores_gemma":[0.9955735,0.001896462,0.0003220236,0.0004683061,0.0000651506,0.0001223509,0.0009073984,0.00001459151,0.0006301687],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001328695,"threshold_uncertainty_score":0.007026851,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2254870088","doi":"10.1016/j.clml.2016.01.001","title":"Differences in Quality of Life Between Bendamustine-Rituximab and R-CHOP/R-CVP in Patients With Previously Untreated Advanced Indolent Non-Hodgkin Lymphoma or Mantle Cell Lymphoma","year":2016,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Dalhousie University; University of Ottawa","funders":"","keywords":"Medicine; Rituximab; Mantle cell lymphoma; Bendamustine; Vincristine; Internal medicine; Prednisone; CHOP; Quality of life (healthcare); Nausea; Cyclophosphamide; Oncology; Lymphoma; Surgery; Chemotherapy","authors":[{"name":"John M. Burke","is_ca":false},{"name":"Richard H. C. Van Der Jagt","is_ca":true},{"name":"Brad S. Kahl","is_ca":false},{"name":"Peter Wood","is_ca":false},{"name":"Tim E. Hawkins","is_ca":false},{"name":"David MacDonald","is_ca":true},{"name":"Mark Hertzberg","is_ca":false},{"name":"David Simpson","is_ca":false},{"name":"Michael Craig","is_ca":false},{"name":"Kathryn S. Kolibaba","is_ca":false},{"name":"Samar Issa","is_ca":false},{"name":"Mihaela Munteanu","is_ca":false},{"name":"Timothy W. Victor","is_ca":false},{"name":"Ian W. Flinn","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03187746019586746,"gpt":0.3067462599513314,"spread":0.274868799755464,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004609665,0.0001477531,0.0003839457,0.0001994304,0.0001748472,0.0004580864,0.0001859481,0.0003306277,0.0009636648],"category_scores_gemma":[0.001737938,0.0000991548,0.0005654915,0.0002971358,0.000232725,0.0004146267,0.0002934875,0.0004819089,0.000116318],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005773728,"about_ca_system_score_gemma":0.000193225,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001536267,"about_ca_topic_score_gemma":0.002490839,"domain_scores_codex":[0.9996623,0.0001303417,0.00002844378,0.00004936732,0.00003594485,0.00009354781],"domain_scores_gemma":[0.9992931,0.0002473012,0.0001927871,0.00002318809,0.00003841523,0.0002053108],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.04268537,0.0007958033,0.9285921,0.00006803565,0.000869175,0.0003751055,0.0002925833,0.0006891469,0.002360793,0.0001013676,0.0003357737,0.02283473],"study_design_scores_gemma":[0.0005729551,0.005625688,0.9921951,0.00000917208,0.000173286,0.0002319552,0.0002379208,0.0004506606,0.0001324251,0.00007812792,0.0002825886,0.00001007844],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9991943,0.0004306695,0.00001465344,0.00003718177,0.000006022332,0.000002878418,0.00004323469,6.58929e-7,0.0002704248],"genre_scores_gemma":[0.999772,0.0000523044,0.000008790481,0.00002870769,0.000006964595,0.000002017579,0.00007485331,3.314403e-7,0.0000540959],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001536267,"threshold_uncertainty_score":0.004189193,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3029322331","doi":"10.1016/j.clml.2020.05.018","title":"Interferon Therapy in Myelofibrosis: Systematic Review and Meta-analysis","year":2020,"lang":"en","type":"review","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; MedImmune; Takeda Canada; Sunesis; Daiichi-Sankyo; CTI Biopharma; National Institutes of Health; Arog Pharmaceuticals; Genentech; Acceleron; Astex Pharmaceuticals; Boehringer Ingelheim; AbbVie; Otsuka America; Memorial Sloan-Kettering Cancer Center; LAM Therapeutics; Novartis; Celgene; Jazz Pharmaceuticals; Takeda Pharmaceuticals U.S.A.; Pfizer; Astellas Pharma US; Astellas Pharma; Constellation Energy Group","keywords":"Medicine; Myelofibrosis; Meta-analysis; Oncology; Internal medicine; Intensive care medicine; Bone marrow","authors":[{"name":"Jan Philipp Bewersdorf","is_ca":false},{"name":"Smith Giri","is_ca":false},{"name":"Rong Wang","is_ca":false},{"name":"Nikolai A. Podoltsev","is_ca":false},{"name":"Christina Williamson","is_ca":false},{"name":"Raajit K. Rampal","is_ca":false},{"name":"Martin S. Tallman","is_ca":false},{"name":"Amer M. Zeidan","is_ca":false},{"name":"Maximilian Stahl","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1528373252975107,"gpt":0.4174541436846737,"spread":0.2646168183871629,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005799622,0.002232903,0.01528718,0.003742966,0.0004741132,0.002380755,0.002038253,0.002112431,0.006801283],"category_scores_gemma":[0.01459861,0.001335529,0.02235989,0.005937373,0.0006092821,0.001743814,0.001758153,0.001924426,0.0004739715],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001827721,"about_ca_system_score_gemma":0.002787883,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006951138,"about_ca_topic_score_gemma":0.02381728,"domain_scores_codex":[0.9960575,0.001725936,0.001137688,0.000488751,0.0003836991,0.0002064857],"domain_scores_gemma":[0.9923723,0.005326928,0.001543581,0.0002318787,0.0003878615,0.0001374465],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.00163875,0.00003006821,0.002755285,0.5240335,0.4572332,0.0001228957,0.0001106959,0.0003539744,0.0002341356,0.0001365265,0.0009777716,0.01237316],"study_design_scores_gemma":[0.0009996144,0.0001562409,0.003698644,0.03377274,0.9585791,0.00009303704,0.00006292572,0.0001246917,0.0000655652,0.0001704823,0.002246394,0.00003064164],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.003245708,0.9954217,0.000300048,0.0001038892,0.00009694247,0.0001398107,0.0004669335,0.00002029555,0.0002046633],"genre_scores_gemma":[0.1160228,0.8795745,0.001658077,0.001039473,0.0001845895,0.0005041144,0.0005898038,0.00002998006,0.0003965239],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01528718,"threshold_uncertainty_score":0.03067172,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2346818737","doi":"10.1016/j.clml.2016.03.005","title":"Bortezomib-Containing Regimens for the Treatment of Newly Diagnosed and Relapsed Amyloid Light Chain Amyloidosis: A Single-Center Experience","year":2016,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Bortezomib; Amyloidosis; AL amyloidosis; Immunoglobulin light chain; Medicine; Amyloid (mycology); Oncology; Single Center; Center (category theory); Internal medicine; Multiple myeloma; Pathology; Immunology; Chemistry","authors":[{"name":"Víctor H. Jiménez‐Zepeda","is_ca":true},{"name":"Peter Duggan","is_ca":false},{"name":"Paola Neri","is_ca":false},{"name":"Nizar J. Bahlis","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02946033452852724,"gpt":0.302709273698907,"spread":0.2732489391703797,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004720454,0.0003008721,0.0006519516,0.0002012853,0.0005567027,0.0007485988,0.0002798073,0.0002975525,0.0006955426],"category_scores_gemma":[0.0009475946,0.0001467669,0.0005493522,0.0004807734,0.0002609763,0.0003322221,0.000311899,0.0006406601,0.0001721503],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005943264,"about_ca_system_score_gemma":0.000512961,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009203421,"about_ca_topic_score_gemma":0.001825819,"domain_scores_codex":[0.999739,0.00008668156,0.00002911718,0.00004653458,0.00004197186,0.0000568129],"domain_scores_gemma":[0.9995285,0.000106328,0.00008706451,0.00003191731,0.00003389508,0.0002123273],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02369934,0.01777165,0.4811899,0.0004141027,0.001412013,0.01403658,0.001747759,0.003164783,0.01784571,0.0006770974,0.004915432,0.4331256],"study_design_scores_gemma":[0.008117854,0.05956781,0.8713843,0.0002871475,0.001083092,0.03833072,0.001325252,0.00268622,0.00470836,0.0005277685,0.01188341,0.00009803636],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9955695,0.002907996,0.0002716607,0.000135369,0.00002063317,0.00005215288,0.00009654673,0.000007530229,0.0009386661],"genre_scores_gemma":[0.9962032,0.002393617,0.0004563345,0.0002227106,0.00005936252,0.00003884496,0.0003265172,0.000009316816,0.0002900038],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0009203421,"threshold_uncertainty_score":0.004312217,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3090860704","doi":"10.1016/j.clml.2020.09.010","title":"Burden of Treatment Among Older Adults With Newly Diagnosed Multiple Myeloma","year":2020,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"National Cancer Institute; National Center for Advancing Translational Sciences; Agency for Healthcare Research and Quality; National Institutes of Health","keywords":"Medicine; Multiple myeloma; Interquartile range; Disease burden; Internal medicine; Comorbidity; Epidemiology; Odds ratio; Malignancy; Logistic regression; Disease; Emergency medicine; Intensive care medicine","authors":[{"name":"Hira Mian","is_ca":true},{"name":"Mark A. Fiala","is_ca":false},{"name":"Tanya M. Wildes","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03434374143750191,"gpt":0.3153407440774412,"spread":0.2809970026399393,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002382542,0.000142645,0.0003369231,0.0007026839,0.0003928145,0.0006666181,0.0002032829,0.0003868269,0.002604592],"category_scores_gemma":[0.001866617,0.000147263,0.0005782634,0.001276951,0.0001108367,0.0006216553,0.0007170099,0.0006243935,0.0001650223],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007757221,"about_ca_system_score_gemma":0.0006227639,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.03013138,"about_ca_topic_score_gemma":0.05391945,"domain_scores_codex":[0.9996601,0.00007158979,0.00004866232,0.0000529832,0.00006931194,0.00009734002],"domain_scores_gemma":[0.9989299,0.00009376634,0.0006088521,0.00002665015,0.0001045173,0.0002361752],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00009634341,0.00004169508,0.9905356,0.00003471251,0.0001067343,0.0000872497,0.0001287636,0.00005822851,0.00008602573,0.00007910835,0.0009644003,0.007781277],"study_design_scores_gemma":[0.000004311133,0.00002374837,0.9988604,0.00002220183,0.00003501744,0.00009742459,0.0003006133,0.00008860059,0.000008035177,0.00003204604,0.0005249411,0.000002597657],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9871278,0.003661765,0.00008768808,0.002075872,0.00006371812,0.00001420708,0.002905087,0.000007006751,0.004056888],"genre_scores_gemma":[0.9958526,0.001964886,0.00006189725,0.0003439584,0.0001196959,0.000008795489,0.001068094,0.000002039546,0.0005779687],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03013138,"threshold_uncertainty_score":0.05991197,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}